Microtubules	B-protein
mediate	O
cellular	O
25-hydroxyvitamin	O
D3	O
trafficking	O
and	O
the	O
genomic	O
response	O
to	O
1	O
,	O
25-dihydroxyvitamin	O
D3	O
in	O
normal	O
human	B-cell_type
monocytes	I-cell_type
.	O

The	O
genomic	O
actions	O
of	O
1	O
,	O
25-dihydroxyvitamin	O
D3	O
(	O
1	O
,	O
25	O
(	O
OH	O
)	O
2D3	O
)	O
are	O
mediated	O
by	O
the	O
intracellular	O
vitamin	B-protein
D	I-protein
receptor	I-protein
(	O
VDR	B-protein
)	O
.	O

Although	O
immunocytochemistry	O
has	O
shown	O
that	O
disruption	O
of	O
microtubular	O
assembly	O
prevents	O
nuclear	O
access	O
of	O
the	O
sterol-VDR	B-protein
complex	I-protein
,	O
the	O
role	O
of	O
microtubules	B-protein
in	O
the	O
response	O
to	O
1	O
,	O
25	O
(	O
OH	O
)	O
2D3	O
has	O
not	O
been	O
studied	O
in	O
viable	B-cell_type
cells	I-cell_type
.	O

Our	O
studies	O
examined	O
this	O
interaction	O
in	O
normal	O
human	B-cell_type
monocytes	I-cell_type
.	O

Monocytes	O
convert	O
25	O
(	O
OH	O
)	O
D3	O
to	O
1	O
,	O
25	O
(	O
OH	O
)	O
2D3	O
and	O
to	O
24-hydroxylated	O
metabolites	O
more	O
polar	O
than	O
1	O
,	O
25	O
(	O
OH	O
)	O
2D3	O
.	O

Microtubule	O
disruption	O
totally	O
abolished	O
the	O
ability	O
of	O
exogenous	O
1	O
,	O
25	O
(	O
OH	O
)	O
2D3	O
to	O
suppress	O
its	O
own	O
synthesis	O
and	O
to	O
induce	O
24-hydroxylase	B-RNA
mRNA	I-RNA
and	O
activity	O
,	O
without	O
affecting	O
either	O
total	O
1	O
,	O
25	O
(	O
OH	O
)	O
2D3	O
uptake	O
or	O
maximal	O
1	O
,	O
25	O
(	O
OH	O
)	O
2D3	O
-VDR	B-protein
binding	O
.	O

Thus	O
,	O
intact	O
microtubules	B-protein
are	O
essential	O
for	O
1	O
,	O
25	O
(	O
OH	O
)	O
2D3-dependent	O
modulation	O
of	O
gene	O
transcription	O
.	O

Interestingly	O
,	O
microtubule	B-protein
disruption	O
also	O
decreased	O
monocyte	B-cell_type
1	O
,	O
25	O
(	O
OH	O
)	O
2D3	O
synthesis	O
,	O
not	O
by	O
decreasing	O
the	O
Vmax	O
of	O
monocyte	B-protein
mitochondrial	I-protein
1	I-protein
alpha-hydroxylase	I-protein
but	O
through	O
an	O
increase	O
in	O
the	O
Km	O
for	O
25	O
(	O
OH	O
)	O
2D3	O
.	O

We	O
examined	O
25	O
(	O
OH	O
)	O
D3	O
transport	O
.	O

Microtubule	O
disruption	O
did	O
not	O
affect	O
total	O
cellular	O
25	O
(	O
OH	O
)	O
D3	O
uptake	O
but	O
reduced	O
its	O
intracellular	O
trafficking	O
to	O
the	O
mitochondria	O
.	O

Thus	O
,	O
microtubules	B-protein
participate	O
in	O
intracellular	O
25	O
(	O
OH	O
)	O
D3	O
transport	O
,	O
and	O
their	O
integrity	O
determines	O
normal	O
1	O
,	O
25	O
(	O
OH	O
)	O
2D3	O
synthesis	O
.	O

THE	NULL
JoUrNAL	NULL
or	NULL
BIOLOGICAL	NULL
CHEMISTRY	NULL
©	NULL
1995	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
for	NULL
Biochemistry	NULL
and	NULL
Molecular	NULL
Biology	NULL
,	NULL
Inc.	NULL
Vol	NULL
.	NULL

270	NULL
,	NULL
No	NULL
.	NULL

38	NULL
,	NULL
Issue	NULL
of	NULL
September	NULL
22	NULL
,	NULL
pp	NULL
.	NULL

22160-22166	NULL
,	NULL
1995	NULL
Printed	NULL
in	NULL
U.S.A.	NULL
Microtubules	NULL
Mediate	NULL
Cellular	NULL
25-Hydroxyvitamin	NULL
D	NULL
;	NULL
,	NULL
Trafficking	NULL
and	NULL
the	NULL
Genomic	NULL
Response	NULL
to	NULL
1,25-Dihydroxyvitamin	NULL
D	NULL
;	NULL
in	NULL
Normal	NULL
Human	NULL
Monocytes*	NULL
(	NULL
Received	NULL
for	NULL
publication	NULL
,	NULL
April	NULL
21	NULL
,	NULL
1995	NULL
)	NULL
Shigehito	NULL
Kamimura	NULL
,	NULL
Maurizio	NULL
Gallieni	NULL
,	NULL
Min	NULL
Zhong	NULL
,	NULL
Walter	NULL
Eduardo	NULL
Slatopolsky	NULL
,	NULL
and	NULL
Adriana	NULL
Dussof	NULL
From	NULL
the	NULL
Department	NULL
of	NULL
Internal	NULL
Medicine	NULL
,	NULL
Renal	NULL
Division	NULL
,	NULL
and	NULL
the	NULL
{	NULL
Department	NULL
of	NULL
Cell	NULL
Biology	NULL
and	NULL
Physiology	NULL
,	NULL
Washington	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
St.	NULL
Louis	NULL
,	NULL
Missouri	NULL
63110-1093	NULL
The	NULL
genomic	NULL
actions	NULL
of	NULL
1,25-dihydroxyvitamin	NULL
D	NULL
;	NULL
(	NULL
1,25	NULL
(	NULL
0H	NULL
)	NULL
;	NULL
D	NULL
;	NULL
)	NULL
are	NULL
mediated	NULL
by	NULL
the	NULL
intracellular	NULL
vitamin	NULL
D	NULL
receptor	NULL
(	NULL
VDR	NULL
)	NULL
.	NULL

Although	NULL
immunocytochemistry	NULL
has	NULL
shown	NULL
that	NULL
disruption	NULL
of	NULL
microtubular	NULL
assembly	NULL
prevents	NULL
nuclear	NULL
access	NULL
of	NULL
the	NULL
sterol-VDR	NULL
complex	NULL
,	NULL
the	NULL
role	NULL
of	NULL
microtubules	NULL
in	NULL
the	NULL
response	NULL
to	NULL
1,25	NULL
(	NULL
O0H	NULL
)	NULL
;	NULL
D	NULL
;	NULL
has	NULL
not	NULL
been	NULL
studied	NULL
in	NULL
viable	NULL
cells	NULL
.	NULL

Our	NULL
studies	NULL
examined	NULL
this	NULL
interaction	NULL
in	NULL
normal	NULL
human	NULL
monocytes	NULL
.	NULL

Monocytes	NULL
convert	NULL
25	NULL
(	NULL
O0H	NULL
)	NULL
D	NULL
;	NULL
to	NULL
1,25	NULL
(	NULL
0H	NULL
)	NULL
;	NULL
D	NULL
;	NULL
and	NULL
to	NULL
24-hydroxylated	NULL
metabolites	NULL
more	NULL
polar	NULL
than	NULL
1,25	NULL
(	NULL
0H	NULL
)	NULL
,	NULL
D	NULL
,	NULL
.	NULL

Microtubule	NULL
disruption	NULL
totally	NULL
abolished	NULL
the	NULL
ability	NULL
of	NULL
exogenous	NULL
1,25	NULL
(	NULL
0H	NULL
)	NULL
,	NULL
D	NULL
,	NULL
to	NULL
suppress	NULL
its	NULL
own	NULL
synthesis	NULL
and	NULL
to	NULL
induce	NULL
24-hydroxylase	NULL
mRNA	NULL
and	NULL
activity	NULL
,	NULL
without	NULL
affecting	NULL
either	NULL
total	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
uptake	NULL
or	NULL
maximal	NULL
1,25	NULL
(	NULL
O0H	NULL
)	NULL
;	NULL
D	NULL
;	NULL
-VDR	NULL
binding	NULL
.	NULL

Thus	NULL
,	NULL
intact	NULL
microtubules	NULL
are	NULL
essential	NULL
for	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
,	NULL
D	NULL
,	NULL
-dependent	NULL
modulation	NULL
of	NULL
gene	NULL
transcription	NULL
.	NULL

Interestingly	NULL
,	NULL
microtubule	NULL
disruption	NULL
also	NULL
decreased	NULL
monocyte	NULL
1,25	NULL
(	NULL
O0H	NULL
)	NULL
;	NULL
D	NULL
;	NULL
synthesis	NULL
,	NULL
not	NULL
by	NULL
decreasing	NULL
the	NULL
V	NULL
,	NULL
,	NULL
,	NULL
...	NULL
of	NULL
monocyte	NULL
mitochondrial	NULL
1	NULL
«	NULL
-hydroxylase	NULL
but	NULL
through	NULL
an	NULL
increase	NULL
in	NULL
the	NULL
K	NULL
,	NULL
,	NULL
,	NULL
for	NULL
25	NULL
(	NULL
OH	NULL
)	NULL
D	NULL
;	NULL
.	NULL

We	NULL
examined	NULL
25	NULL
(	NULL
OH	NULL
)	NULL
D	NULL
;	NULL
transport	NULL
.	NULL

Microtubule	NULL
disruption	NULL
did	NULL
not	NULL
affect	NULL
total	NULL
cellular	NULL
25	NULL
(	NULL
OH	NULL
)	NULL
D	NULL
,	NULL
uptake	NULL
but	NULL
reduced	NULL
its	NULL
intracellular	NULL
trafficking	NULL
to	NULL
the	NULL
mitochondria	NULL
.	NULL

Thus	NULL
,	NULL
microtubules	NULL
participate	NULL
in	NULL
intracellular	NULL
25	NULL
(	NULL
OH	NULL
)	NULL
D	NULL
;	NULL
transport	NULL
,	NULL
and	NULL
their	NULL
integrity	NULL
determines	NULL
normal	NULL
1,25	NULL
(	NULL
O0H	NULL
)	NULL
;	NULL
D	NULL
;	NULL
,	NULL
synthesis	NULL
.	NULL

The	NULL
most	NULL
active	NULL
metabolite	NULL
of	NULL
vitamin	NULL
D	NULL
,	NULL
1,25-dihydroxyvitamin	NULL
D	NULL
;	NULL
(	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
2D3	NULL
)	NULL
)	NULL
,1	NULL
is	NULL
a	NULL
potent	NULL
steroid	NULL
hormone	NULL
.	NULL

Similar	NULL
to	NULL
other	NULL
steroids	NULL
,	NULL
its	NULL
genomic	NULL
actions	NULL
require	NULL
binding	NULL
to	NULL
its	NULL
intracellular	NULL
receptor	NULL
and	NULL
interaction	NULL
of	NULL
the	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
-vita-min	NULL
D	NULL
receptor	NULL
(	NULL
VDR	NULL
)	NULL
complex	NULL
with	NULL
specific	NULL
vitamin	NULL
D	NULL
responsive	NULL
regions	NULL
in	NULL
the	NULL
genome	NULL
(	NULL
1	NULL
,	NULL
2	NULL
)	NULL
.	NULL

It	NULL
has	NULL
been	NULL
suggested	NULL
recently	NULL
that	NULL
hormone-free	NULL
glucocorticoid	NULL
receptors	NULL
are	NULL
located	NULL
predominantly	NULL
in	NULL
the	NULL
cytoplasm	NULL
,	NULL
and	NULL
,	NULL
*	NULL
This	NULL
work	NULL
was	NULL
supported	NULL
in	NULL
part	NULL
by	NULL
United	NULL
States	NULL
Public	NULL
Health	NULL
Service	NULL
NIDDK	NULL
,	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
Grants	NULL
DK-09976	NULL
and	NULL
DK-07126	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1784	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

§	NULL
Recipient	NULL
of	NULL
a	NULL
research	NULL
fellowship	NULL
from	NULL
Consejo	NULL
Nacional	NULL
de	NULL
Inves-tigaciones	NULL
Cientificas	NULL
y	NULL
Técnicas	NULL
(	NULL
CONICET	NULL
)	NULL
,	NULL
Argentina	NULL
.	NULL

«	NULL
To	NULL
whom	NULL
correspondence	NULL
and	NULL
reprint	NULL
requests	NULL
should	NULL
be	NULL
addressed	NULL
:	NULL
Dept	NULL
.	NULL

of	NULL
Internal	NULL
Medicine	NULL
,	NULL
Renal	NULL
Division	NULL
,	NULL
Washington	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
660	NULL
South	NULL
Euclid	NULL
Ave.	NULL
,	NULL
Box	NULL
8126	NULL
,	NULL
St.	NULL
Louis	NULL
,	NULL
MO	NULL
63110-1093	NULL
.	NULL

Tel	NULL
.	NULL

:	NULL
314-862-8248	NULL
;	NULL
Fax	NULL
:	NULL
314-362-8237	NULL
.	NULL

'The	NULL
abbreviations	NULL
used	NULL
are	NULL
:	NULL
1,25	NULL
(	NULL
O0H	NULL
)	NULL
,	NULL
D	NULL
,	NULL
,	NULL
1,25-dihydroxyvitamin	NULL
D	NULL
;	NULL
;	NULL
VDR	NULL
,	NULL
vitamin	NULL
D	NULL
receptor	NULL
;	NULL
25	NULL
(	NULL
OH	NULL
)	NULL
D	NULL
;	NULL
,	NULL
25-hydroxyvitamin	NULL
D	NULL
,	NULL
;	NULL
HPLC	NULL
,	NULL
high	NULL
performance	NULL
liquid	NULL
chromatography	NULL
;	NULL
PBS	NULL
,	NULL
phosphate-buffered	NULL
sa-line	NULL
;	NULL
PIPES	NULL
,	NULL
piperazine-N	NULL
,	NULL
N'-bis	NULL
(	NULL
2-ethanesulfonic	NULL
acid	NULL
)	NULL
or	NULL
1,4-pipera-zinediethanesulfonic	NULL
acid	NULL
.	NULL

after	NULL
the	NULL
addition	NULL
of	NULL
steroid	NULL
,	NULL
they	NULL
are	NULL
rapidly	NULL
translocated	NULL
to	NULL
the	NULL
nucleus	NULL
(	NULL
3-6	NULL
)	NULL
.	NULL

The	NULL
transfer	NULL
of	NULL
glucocorticoid	NULL
receptor	NULL
into	NULL
the	NULL
nucleus	NULL
involves	NULL
translocation	NULL
along	NULL
microtubules	NULL
as	NULL
revealed	NULL
by	NULL
immunofluorescent	NULL
studies	NULL
(	NULL
7	NULL
)	NULL
in	NULL
a	NULL
process	NULL
that	NULL
is	NULL
driven	NULL
by	NULL
tubulin-associated	NULL
dynein	NULL
motors	NULL
(	NULL
8	NULL
)	NULL
.	NULL

In	NULL
the	NULL
case	NULL
of	NULL
vitamin	NULL
D	NULL
,	NULL
there	NULL
is	NULL
some	NULL
controversy	NULL
as	NULL
to	NULL
whether	NULL
apoVDRs	NULL
reside	NULL
only	NULL
in	NULL
the	NULL
nucleus	NULL
like	NULL
the	NULL
thyroid	NULL
hormone	NULL
receptor	NULL
(	NULL
9	NULL
)	NULL
or	NULL
whether	NULL
they	NULL
can	NULL
undergo	NULL
ligand-de-pendent	NULL
translocation	NULL
like	NULL
the	NULL
glucocorticoid	NULL
receptor	NULL
(	NULL
10	NULL
,	NULL
11	NULL
)	NULL
.	NULL

Using	NULL
a	NULL
recently	NULL
developed	NULL
fluorescent	NULL
ligand	NULL
,	NULL
Barsony	NULL
et	NULL
al	NULL
.	NULL

(	NULL
12	NULL
)	NULL
were	NULL
able	NULL
to	NULL
demonstrate	NULL
the	NULL
cytoplasmic	NULL
localization	NULL
of	NULL
the	NULL
VDR	NULL
in	NULL
viable	NULL
human	NULL
skin	NULL
fibroblasts	NULL
,	NULL
porcine	NULL
kidney	NULL
epithelial	NULL
cells	NULL
,	NULL
human	NULL
breast	NULL
cancer	NULL
cells	NULL
,	NULL
and	NULL
rat	NULL
osteosarcoma	NULL
cells	NULL
,	NULL
supporting	NULL
previous	NULL
immunocytochemical	NULL
findings	NULL
in	NULL
fixed	NULL
human	NULL
fibroblasts	NULL
(	NULL
13	NULL
)	NULL
and	NULL
osteoblasts	NULL
(	NULL
14	NULL
)	NULL
.	NULL

Although	NULL
immunocytology	NULL
has	NULL
shown	NULL
that	NULL
cytoplasmic	NULL
VDR	NULL
co-localizes	NULL
with	NULL
tubulin	NULL
and	NULL
that	NULL
disruption	NULL
of	NULL
microtubular	NULL
assembly	NULL
blocks	NULL
the	NULL
translocation	NULL
of	NULL
the	NULL
1,25	NULL
(	NULL
O0H	NULL
)	NULL
,	NULL
D	NULL
,	NULL
-VDR	NULL
complex	NULL
into	NULL
the	NULL
nucleus	NULL
(	NULL
15	NULL
)	NULL
in	NULL
microwave	NULL
fixed	NULL
fibroblasts	NULL
,	NULL
the	NULL
role	NULL
of	NULL
microtubules	NULL
on	NULL
VDR	NULL
transport	NULL
in	NULL
viable	NULL
cells	NULL
has	NULL
never	NULL
been	NULL
evaluated	NULL
.	NULL

We	NULL
hypothesized	NULL
that	NULL
if	NULL
this	NULL
intracellular	NULL
transport	NULL
system	NULL
is	NULL
of	NULL
physiological	NULL
relevance	NULL
,	NULL
the	NULL
genomic	NULL
response	NULL
to	NULL
1,25	NULL
(	NULL
0H	NULL
)	NULL
,	NULL
D	NULL
;	NULL
should	NULL
be	NULL
impaired	NULL
with	NULL
alterations	NULL
in	NULL
the	NULL
structure	NULL
or	NULL
function	NULL
of	NULL
the	NULL
microtubule	NULL
network	NULL
.	NULL

We	NULL
tested	NULL
this	NULL
hypothesis	NULL
in	NULL
normal	NULL
human	NULL
monocytes	NULL
.	NULL

Human	NULL
monocytes	NULL
express	NULL
receptors	NULL
for	NULL
1,25	NULL
(	NULL
O0H	NULL
)	NULL
,	NULL
D	NULL
;	NULL
that	NULL
are	NULL
indistinguishable	NULL
from	NULL
those	NULL
described	NULL
in	NULL
classical	NULL
1,25	NULL
(	NULL
O0H	NULL
)	NULL
,	NULL
D	NULL
;	NULL
target	NULL
tissues	NULL
(	NULL
16	NULL
)	NULL
,	NULL
and	NULL
the	NULL
interactions	NULL
of	NULL
1,25	NULL
(	NULL
0H	NULL
)	NULL
,	NULL
D	NULL
;	NULL
,	NULL
with	NULL
monocytes-macrophages	NULL
have	NULL
critical	NULL
implications	NULL
for	NULL
the	NULL
regulation	NULL
of	NULL
immune	NULL
responses	NULL
(	NULL
17-20	NULL
)	NULL
.	NULL

Our	NULL
laboratory	NULL
has	NULL
demonstrated	NULL
that	NULL
peripheral	NULL
blood	NULL
monocytes	NULL
from	NULL
normal	NULL
individuals	NULL
constitutively	NULL
express	NULL
1a-hydroxylase	NULL
,	NULL
the	NULL
enzyme	NULL
responsible	NULL
for	NULL
the	NULL
conversion	NULL
of	NULL
25-hydroxyvitamin	NULL
D	NULL
;	NULL
(	NULL
25	NULL
(	NULL
OH	NULL
)	NULL
D	NULL
;	NULL
)	NULL
to	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
(	NULL
21	NULL
)	NULL
.	NULL

We	NULL
have	NULL
also	NULL
shown	NULL
that	NULL
when	NULL
peripheral	NULL
blood	NULL
monocytes	NULL
were	NULL
exposed	NULL
to	NULL
physiological	NULL
concentrations	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
,	NULL
La-hydroxylase	NULL
activity	NULL
is	NULL
markedly	NULL
suppressed	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
exogenous	NULL
1,25	NULL
(	NULL
0H	NULL
)	NULL
;	NULL
,	NULL
D	NULL
;	NULL
promotes	NULL
an	NULL
induction	NULL
of	NULL
vitamin	NULL
D	NULL
catabolism	NULL
by	NULL
increasing	NULL
24-hydroxylase	NULL
mRNA	NULL
and	NULL
activity	NULL
(	NULL
22	NULL
)	NULL
.	NULL

Because	NULL
both	NULL
effects	NULL
of	NULL
the	NULL
sterol	NULL
require	NULL
at	NULL
least	NULL
2	NULL
h	NULL
of	NULL
exposure	NULL
to	NULL
1,25	NULL
(	NULL
O0H	NULL
)	NULL
;	NULL
D	NULL
;	NULL
(	NULL
22	NULL
)	NULL
,	NULL
it	NULL
is	NULL
likely	NULL
that	NULL
the	NULL
inhibition	NULL
of	NULL
1,25	NULL
(	NULL
O0H	NULL
)	NULL
,	NULL
D	NULL
;	NULL
production	NULL
by	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
also	NULL
involves	NULL
a	NULL
genomic	NULL
mechanism	NULL
.	NULL

In	NULL
the	NULL
present	NULL
studies	NULL
,	NULL
we	NULL
used	NULL
this	NULL
human	NULL
monocyte	NULL
model	NULL
to	NULL
assess	NULL
the	NULL
physiological	NULL
relevance	NULL
of	NULL
microtubule	NULL
integrity	NULL
in	NULL
the	NULL
response	NULL
to	NULL
1,25	NULL
(	NULL
O0H	NULL
)	NULL
,	NULL
D	NULL
;	NULL
.	NULL

This	NULL
report	NULL
demonstrates	NULL
for	NULL
the	NULL
first	NULL
time	NULL
that	NULL
integrity	NULL
of	NULL
the	NULL
microtubule	NULL
network	NULL
is	NULL
critical	NULL
for	NULL
a	NULL
normal	NULL
genomic	NULL
response	NULL
to	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
and	NULL
that	NULL
an	NULL
intracel-	NULL
28	NULL
.	NULL

Kamimura	NULL
,	NULL
M.	NULL
Gallieni	NULL
,	NULL
E.	NULL
Slatopolsky	NULL
,	NULL
and	NULL
A.	NULL
Dusso	NULL
,	NULL
unpublished	NULL
data	NULL
.	NULL

22160	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
Role	NULL
of	NULL
Microtubules	NULL
in	NULL
Vitamin	NULL
D	NULL
Transport	NULL
and	NULL
Action	NULL
lular	NULL
tubulin-	NULL
25	NULL
(	NULL
OH	NULL
)	NULL
D	NULL
;	NULL
transport	NULL
system	NULL
mediates	NULL
the	NULL
delivery	NULL
of	NULL
25	NULL
(	NULL
OH	NULL
)	NULL
D	NULL
;	NULL
to	NULL
mitochondria	NULL
,	NULL
thus	NULL
modulating	NULL
the	NULL
rate	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
synthesis	NULL
by	NULL
monocytes	NULL
.	NULL

EXPERIMENTAL	NULL
PROCEDURES	NULL
Materials-1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
was	NULL
kindly	NULL
provided	NULL
by	NULL
Dr.	NULL
Milan	NULL
Uskok-ovie	NULL
(	NULL
Hoffman-La	NULL
Roche	NULL
)	NULL
.	NULL

1,25-Dihydroxy	NULL
[	NULL
26,27-methyl-*H	NULL
]	NULL
cholecalcif-erol	NULL
(	NULL
specific	NULL
activity	NULL
,	NULL
120-174	NULL
Ci/mmol	NULL
)	NULL
and	NULL
25-hydroxy	NULL
[	NULL
26	NULL
(	NULL
27	NULL
)	NULL
-methyl-*H	NULL
Jcholecalciferol	NULL
(	NULL
specific	NULL
activity	NULL
,	NULL
28	NULL
Ci/mmol	NULL
)	NULL
were	NULL
obtained	NULL
from	NULL
Amersham	NULL
.	NULL

Colchicine	NULL
,	NULL
vinblastine	NULL
,	NULL
isocitrate	NULL
,	NULL
and	NULL
NADPH	NULL
were	NULL
obtained	NULL
from	NULL
Sigma	NULL
.	NULL

Culture	NULL
of	NULL
Human	NULL
Monocytes-Peripheral	NULL
blood	NULL
was	NULL
obtained	NULL
from	NULL
normal	NULL
volunteers	NULL
by	NULL
venipuncture	NULL
.	NULL

Mononuclear	NULL
leukocytes	NULL
were	NULL
isolated	NULL
using	NULL
a	NULL
Ficoll-Hypaque	NULL
gradient	NULL
(	NULL
Pharmacia	NULL
Biotech	NULL
Inc.	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
plated	NULL
in	NULL
six-well	NULL
plates	NULL
at	NULL
a	NULL
concentration	NULL
of	NULL
7	NULL
X	NULL
10°	NULL
to	NULL
10	NULL
``	NULL
cells	NULL
per	NULL
well	NULL
in	NULL
1	NULL
ml	NULL
of	NULL
RPMI	NULL
1640	NULL
containing	NULL
1	NULL
%	NULL
fatty	NULL
acid-free	NULL
albumin	NULL
,	NULL
50,000	NULL
units/liter	NULL
penicillin	NULL
G	NULL
sodium	NULL
,	NULL
50,000	NULL
pg/liter	NULL
streptomycin	NULL
sulfate	NULL
,	NULL
10	NULL
mm	NULL
HEPES	NULL
,	NULL
and	NULL
0.8	NULL
mM	NULL
NaHCO	NULL
,	NULL
.	NULL

After	NULL
an	NULL
incubation	NULL
period	NULL
of	NULL
18	NULL
h	NULL
at	NULL
37	NULL
°C	NULL
,	NULL
media	NULL
and	NULL
nonadherent	NULL
cells	NULL
were	NULL
removed	NULL
,	NULL
and	NULL
adherent	NULL
cells	NULL
were	NULL
washed	NULL
(	NULL
once	NULL
with	NULL
2	NULL
ml	NULL
of	NULL
phosphate-buffered	NULL
saline	NULL
(	NULL
PBS	NULL
)	NULL
and	NULL
twice	NULL
with	NULL
1	NULL
ml	NULL
of	NULL
RPMI	NULL
1640	NULL
containing	NULL
0.1	NULL
%	NULL
fatty	NULL
acid-free	NULL
albumin	NULL
)	NULL
.	NULL

More	NULL
than	NULL
95	NULL
%	NULL
of	NULL
the	NULL
adherent	NULL
cells	NULL
stained	NULL
positively	NULL
for	NULL
macrophage-specific	NULL
«	NULL
-naphthyl	NULL
acetate	NULL
esterase	NULL
activity	NULL
(	NULL
23	NULL
)	NULL
.	NULL

This	NULL
adherent	NULL
cell	NULL
population	NULL
was	NULL
used	NULL
in	NULL
all	NULL
studies	NULL
.	NULL

The	NULL
Effect	NULL
of	NULL
Exogenous	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
on	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
,	NULL
Synthesis	NULL
and	NULL
25	NULL
(	NULL
OH	NULL
)	NULL
D	NULL
,	NULL
Catabolism	NULL
by	NULL
Monocytes-Adherent	NULL
cells	NULL
were	NULL
incubated	NULL
in	NULL
1	NULL
ml	NULL
of	NULL
RPMI	NULL
1640	NULL
containing	NULL
1	NULL
%	NULL
fatty-acid-free	NULL
albumin	NULL
(	NULL
incubation	NULL
media	NULL
)	NULL
and	NULL
0	NULL
or	NULL
0.24	NULL
nM	NULL
1,25	NULL
(	NULL
O0H	NULL
)	NULL
;	NULL
D	NULL
,	NULL
;	NULL
for	NULL
4	NULL
h.	NULL
Media	NULL
were	NULL
removed	NULL
,	NULL
and	NULL
1	NULL
ml	NULL
of	NULL
fresh	NULL
incubation	NULL
media	NULL
(	NULL
0.1	NULL
%	NULL
albumin	NULL
)	NULL
was	NULL
added	NULL
per	NULL
well	NULL
.	NULL

The	NULL
synthesis	NULL
of	NULL
1,25	NULL
(	NULL
O0H	NULL
)	NULL
,	NULL
D	NULL
;	NULL
and	NULL
metabolites	NULL
more	NULL
polar	NULL
than	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
was	NULL
initiated	NULL
by	NULL
adding	NULL
0.1	NULL
wCi	NULL
of	NULL
25-hydroxy	NULL
[	NULL
26	NULL
(	NULL
27	NULL
)	NULL
-methyl-*H	NULL
]	NULL
chole-calciferol	NULL
in	NULL
20	NULL
pl	NULL
of	NULL
media	NULL
per	NULL
well	NULL
.	NULL

Reactions	NULL
were	NULL
stopped	NULL
after	NULL
a	NULL
1-h	NULL
incubation	NULL
at	NULL
37°C	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
1	NULL
ml	NULL
of	NULL
acetonitrile	NULL
;	NULL
100	NULL
ng	NULL
of	NULL
radioinert	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
were	NULL
added	NULL
to	NULL
the	NULL
wells	NULL
to	NULL
monitor	NULL
recoveries	NULL
.	NULL

Cells	NULL
were	NULL
scraped	NULL
using	NULL
a	NULL
rubber	NULL
policeman	NULL
,	NULL
and	NULL
cells	NULL
and	NULL
media	NULL
were	NULL
collected	NULL
.	NULL

Wells	NULL
were	NULL
washed	NULL
with	NULL
2	NULL
ml	NULL
of	NULL
acetonitrile	NULL
:	NULL
water	NULL
(	NULL
1:1	NULL
)	NULL
,	NULL
scraped	NULL
,	NULL
and	NULL
pooled	NULL
with	NULL
the	NULL
previously	NULL
collected	NULL
fraction	NULL
.	NULL

Samples	NULL
were	NULL
vortexed	NULL
for	NULL
30	NULL
s	NULL
and	NULL
centrifuged	NULL
at	NULL
2,500	NULL
%	NULL
g	NULL
for	NULL
15	NULL
min	NULL
.	NULL

Vitamin	NULL
D	NULL
metabolites	NULL
were	NULL
obtained	NULL
from	NULL
the	NULL
supernatants	NULL
using	NULL
C	NULL
;	NULL
&	NULL
cartridges	NULL
(	NULL
Fisher	NULL
Scientific	NULL
)	NULL
and	NULL
the	NULL
extraction	NULL
procedure	NULL
developed	NULL
by	NULL
Reinhardt	NULL
et	NULL
al	NULL
.	NULL

(	NULL
24	NULL
)	NULL
.	NULL

The	NULL
vitamin	NULL
D	NULL
metabolite	NULL
fraction	NULL
eluting	NULL
with	NULL
acetonitrile	NULL
was	NULL
collected	NULL
,	NULL
dried	NULL
under	NULL
nitrogen	NULL
,	NULL
and	NULL
purified	NULL
by	NULL
HPLC	NULL
using	NULL
a	NULL
Zorbax	NULL
Sil	NULL
column	NULL
(	NULL
Phenomenex	NULL
,	NULL
Torrance	NULL
,	NULL
CA	NULL
)	NULL
with	NULL
3	NULL
%	NULL
iso-propyl	NULL
alcohol	NULL
in	NULL
methylene	NULL
chloride	NULL
as	NULL
solvent	NULL
.	NULL

Average	NULL
recoveries	NULL
of	NULL
radioinert	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
were	NULL
higher	NULL
than	NULL
75	NULL
%	NULL
.	NULL

Immediately	NULL
after	NULL
the	NULL
elution	NULL
of	NULL
the	NULL
D	NULL
;	NULL
peak	NULL
,	NULL
the	NULL
column	NULL
was	NULL
stripped	NULL
with	NULL
4	NULL
ml	NULL
of	NULL
methanol	NULL
to	NULL
quantitate	NULL
the	NULL
synthesis	NULL
of	NULL
metabolites	NULL
more	NULL
polar	NULL
than	NULL
1,25	NULL
(	NULL
O0H	NULL
)	NULL
;	NULL
D	NULL
;	NULL
(	NULL
polar	NULL
metabolites	NULL
)	NULL
.	NULL

Tritium	NULL
eluting	NULL
in	NULL
the	NULL
1,25	NULL
(	NULL
O0H	NULL
)	NULL
,	NULL
D	NULL
;	NULL
and	NULL
more	NULL
polar	NULL
metabolite	NULL
HPLC	NULL
fractions	NULL
was	NULL
counted	NULL
in	NULL
a	NULL
liquid	NULL
scintillation	NULL
counter	NULL
(	NULL
ICN	NULL
Micromedic	NULL
System	NULL
Inc.	NULL
,	NULL
Huntsville	NULL
,	NULL
AL	NULL
)	NULL
.	NULL

Radioactivity	NULL
eluting	NULL
with	NULL
the	NULL
methanol	NULL
strip	NULL
from	NULL
wells	NULL
incubated	NULL
with	NULL
media	NULL
only	NULL
was	NULL
considered	NULL
as	NULL
nonspecific	NULL
oxidation	NULL
of	NULL
25	NULL
(	NULL
OH	NULL
)	NULL
D	NULL
;	NULL
and	NULL
subtracted	NULL
as	NULL
background	NULL
.	NULL

Results	NULL
were	NULL
normalized	NULL
per	NULL
pg	NULL
of	NULL
DNA	NULL
measured	NULL
using	NULL
the	NULL
ethidium	NULL
bromide	NULL
method	NULL
(	NULL
25	NULL
)	NULL
.	NULL

In	NULL
each	NULL
experiment	NULL
,	NULL
determinations	NULL
were	NULL
performed	NULL
in	NULL
triplicate	NULL
.	NULL

The	NULL
Effect	NULL
of	NULL
Microtubule	NULL
Disrupting	NULL
Agents	NULL
on	NULL
the	NULL
Suppression	NULL
of	NULL
1,25	NULL
(	NULL
0H	NULL
)	NULL
,	NULL
D	NULL
,	NULL
Synthesis	NULL
and	NULL
the	NULL
Stimulation	NULL
of	NULL
Vitamin	NULL
D	NULL
Catabolism	NULL
by	NULL
Exogenous	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
,	NULL
in	NULL
Monocytes-Positive	NULL
controls	NULL
were	NULL
adherent	NULL
cells	NULL
exposed	NULL
for	NULL
4	NULL
h	NULL
to	NULL
0	NULL
or	NULL
0.24	NULL
nM	NULL
1,25	NULL
(	NULL
O0H	NULL
)	NULL
,	NULL
D	NULL
;	NULL
.	NULL

In	NULL
the	NULL
Pre	NULL
group	NULL
,	NULL
adherent	NULL
cells	NULL
were	NULL
exposed	NULL
to	NULL
colchicine	NULL
(	NULL
from	NULL
0	NULL
to	NULL
750	NULL
uM	NULL
as	NULL
specified	NULL
for	NULL
each	NULL
particular	NULL
experiment	NULL
)	NULL
or	NULL
vinblastine	NULL
(	NULL
50	NULL
um	NULL
)	NULL
for	NULL
30	NULL
min	NULL
,	NULL
washed	NULL
and	NULL
incubated	NULL
in	NULL
1	NULL
ml	NULL
of	NULL
incubation	NULL
media	NULL
with	NULL
0	NULL
or	NULL
0.24	NULL
nM	NULL
1,25	NULL
(	NULL
0H	NULL
)	NULL
;	NULL
D	NULL
;	NULL
for	NULL
4	NULL
h.	NULL
In	NULL
the	NULL
Post	NULL
group	NULL
,	NULL
adherent	NULL
cells	NULL
were	NULL
first	NULL
incubated	NULL
with	NULL
0	NULL
or	NULL
0.24	NULL
nM	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
and	NULL
then	NULL
exposed	NULL
to	NULL
colchicine	NULL
for	NULL
30	NULL
min	NULL
.	NULL

The	NULL
effect	NULL
of	NULL
the	NULL
reversible	NULL
microtubule	NULL
disrupting	NULL
agent	NULL
,	NULL
nocodazole	NULL
,	NULL
on	NULL
the	NULL
response	NULL
to	NULL
1,25	NULL
(	NULL
O0H	NULL
)	NULL
,	NULL
D	NULL
,	NULL
was	NULL
examined	NULL
as	NULL
follows	NULL
.	NULL

Adherent	NULL
monocytes	NULL
were	NULL
treated	NULL
with	NULL
0	NULL
or	NULL
10	NULL
um	NULL
nocodazole	NULL
for	NULL
30	NULL
min	NULL
before	NULL
a	NULL
co-incubation	NULL
with	NULL
0.24	NULL
nw	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
and	NULL
10	NULL
uM	NULL
nocodazole	NULL
for	NULL
4	NULL
h.	NULL
To	NULL
test	NULL
reversibility	NULL
of	NULL
the	NULL
effect	NULL
of	NULL
nocodazole	NULL
,	NULL
adherent	NULL
cells	NULL
were	NULL
exposed	NULL
to	NULL
0	NULL
or	NULL
10	NULL
pM	NULL
nocodazole	NULL
(	NULL
dissolved	NULL
in	NULL
1	NULL
Ll	NULL
of	NULL
dimethyl	NULL
sulfox-ide	NULL
)	NULL
for	NULL
4	NULL
%	NULL
h	NULL
;	NULL
cells	NULL
were	NULL
then	NULL
washed	NULL
,	NULL
and	NULL
the	NULL
media	NULL
were	NULL
replaced	NULL
by	NULL
fresh	NULL
nocodazole-free	NULL
incubation	NULL
media	NULL
.	NULL

Monocytes	NULL
were	NULL
allowed	NULL
to	NULL
recover	NULL
for	NULL
4	NULL
h.	NULL
Control	NULL
and	NULL
nocodazole-treated	NULL
monocytes	NULL
were	NULL
then	NULL
exposed	NULL
to	NULL
0.24	NULL
nM	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
for	NULL
4	NULL
h.	NULL
In	NULL
each	NULL
independent	NULL
experiment	NULL
,	NULL
the	NULL
synthesis	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
and	NULL
of	NULL
polar	NULL
metabolites	NULL
by	NULL
monocytes	NULL
from	NULL
the	NULL
same	NULL
individual	NULL
was	NULL
measured	NULL
22161	NULL
in	NULL
triplicate	NULL
,	NULL
and	NULL
the	NULL
steady	NULL
state	NULL
24-hydroxylase	NULL
mRNA	NULL
levels	NULL
were	NULL
quantified	NULL
in	NULL
duplicate	NULL
using	NULL
a	NULL
ribonuclease	NULL
protection	NULL
assay	NULL
.	NULL

Ribonuclease	NULL
Protection	NULL
Assay-RNA	NULL
from	NULL
monocytes	NULL
was	NULL
obtained	NULL
using	NULL
the	NULL
commercially	NULL
available	NULL
rapid	NULL
RNA	NULL
isolation	NULL
method	NULL
,	NULL
RNAzol	NULL
(	NULL
Tele	NULL
Test	NULL
Inc.	NULL
,	NULL
Friendswood	NULL
,	NULL
TX	NULL
)	NULL
.	NULL

Riboprobes	NULL
for	NULL
Human	NULL
24-Hydroxylase-A	NULL
BamHI	NULL
restriction	NULL
fragment	NULL
from	NULL
the	NULL
human	NULL
24-hydroxylase	NULL
cDNA	NULL
(	NULL
generously	NULL
provided	NULL
by	NULL
Dr.	NULL
Hector	NULL
DeLuca	NULL
)	NULL
corresponding	NULL
to	NULL
the	NULL
bases	NULL
1657	NULL
to	NULL
1999	NULL
of	NULL
the	NULL
published	NULL
sequence	NULL
was	NULL
subcloned	NULL
in	NULL
Bluescript	NULL
KS	NULL
(	NULL
Stratagene	NULL
)	NULL
.	NULL

The	NULL
antisense	NULL
control	NULL
template	NULL
for	NULL
human	NULL
glyceraldehyde-3-phosphate	NULL
dehydrogenase	NULL
(	NULL
pTRI-GAPDH	NULL
)	NULL
was	NULL
purchased	NULL
from	NULL
Ambion	NULL
(	NULL
Austin	NULL
,	NULL
TX	NULL
)	NULL
.	NULL

DDel	NULL
digestion	NULL
of	NULL
the	NULL
linearized	NULL
pTRI-GAPDH	NULL
resulted	NULL
in	NULL
a	NULL
shortened	NULL
template	NULL
that	NULL
allowed	NULL
the	NULL
synthesis	NULL
of	NULL
a	NULL
*°P-labeled	NULL
transcript	NULL
with	NULL
a	NULL
150-nucleotide	NULL
homology	NULL
with	NULL
human	NULL
glyceraldehyde-3-phosphate	NULL
dehydrogenase	NULL
mRNA	NULL
.	NULL

Radiolabeled	NULL
antisense	NULL
RNAs	NULL
were	NULL
produced	NULL
using	NULL
T7	NULL
RNA	NULL
polymerase	NULL
and	NULL
[	NULL
a*P	NULL
]	NULL
CTP	NULL
(	NULL
Amersham	NULL
)	NULL
.	NULL

The	NULL
size	NULL
of	NULL
the	NULL
protected	NULL
fragment	NULL
for	NULL
the	NULL
human	NULL
24-hydroxylase	NULL
was	NULL
342	NULL
base	NULL
pairs	NULL
.	NULL

Monocyte	NULL
RNA	NULL
samples	NULL
were	NULL
dissolved	NULL
in	NULL
4	NULL
pl	NULL
of	NULL
diethyl	NULL
pyrocarbon-ate	NULL
water	NULL
and	NULL
mixed	NULL
with	NULL
26	NULL
Ll	NULL
of	NULL
hybridization	NULL
buffer	NULL
(	NULL
80	NULL
%	NULL
formamide	NULL
,	NULL
50	NULL
mm	NULL
PIPES	NULL
,	NULL
pH	NULL
6.4	NULL
,	NULL
400	NULL
mM	NULL
NaCl	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
)	NULL
containing	NULL
the	NULL
*°P-labeled	NULL
riboprobes	NULL
for	NULL
human	NULL
24-hydroxylase	NULL
and	NULL
glyceraldehyde-3-phosphate	NULL
dehydrogenase	NULL
.	NULL

The	NULL
specific	NULL
activity	NULL
of	NULL
the	NULL
riboprobe	NULL
for	NULL
glyceraldehyde-3-phosphate	NULL
dehydrogenase	NULL
was	NULL
reduced	NULL
5-fold	NULL
to	NULL
obtain	NULL
labeled	NULL
,	NULL
protected	NULL
fragments	NULL
of	NULL
similar	NULL
radioactivity	NULL
.	NULL

After	NULL
hybridization	NULL
at	NULL
45°C	NULL
for	NULL
16	NULL
h	NULL
,	NULL
the	NULL
samples	NULL
were	NULL
mixed	NULL
with	NULL
150	NULL
ul	NULL
of	NULL
ribonuclease	NULL
digestion	NULL
mixture	NULL
containing	NULL
2	NULL
ug	NULL
of	NULL
ribonuclease	NULL
TI	NULL
in	NULL
10	NULL
mM	NULL
Tris-HCl	NULL
,	NULL
pH	NULL
5.0	NULL
,	NULL
300	NULL
mM	NULL
NaCl	NULL
,	NULL
5	NULL
mM	NULL
EDTA	NULL
,	NULL
and	NULL
incubated	NULL
at	NULL
87	NULL
°C	NULL
for	NULL
15	NULL
min	NULL
.	NULL

Proteinase	NULL
K	NULL
(	NULL
50	NULL
pg	NULL
)	NULL
and	NULL
20	NULL
pl	NULL
of	NULL
5	NULL
%	NULL
SDS	NULL
were	NULL
added	NULL
,	NULL
and	NULL
the	NULL
samples	NULL
were	NULL
incubated	NULL
for	NULL
15	NULL
min	NULL
at	NULL
37	NULL
°C	NULL
.	NULL

Following	NULL
phenol	NULL
:	NULL
chloroform	NULL
extraction	NULL
and	NULL
ethanol	NULL
precipitation	NULL
,	NULL
the	NULL
samples	NULL
were	NULL
resolved	NULL
on	NULL
a	NULL
5	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
.	NULL

The	NULL
dried	NULL
gel	NULL
was	NULL
exposed	NULL
to	NULL
x-ray	NULL
film	NULL
for	NULL
120	NULL
h	NULL
,	NULL
and	NULL
the	NULL
bands	NULL
were	NULL
quantified	NULL
by	NULL
scanning	NULL
densitometry	NULL
.	NULL

Total	NULL
Cellular	NULL
Uptake	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
or	NULL
25	NULL
(	NULL
OH	NULL
)	NULL
D	NULL
,	NULL
by	NULL
Human	NULL
Peripheral	NULL
Monocytes-A	NULL
modification	NULL
of	NULL
the	NULL
procedure	NULL
reported	NULL
by	NULL
Keenan	NULL
and	NULL
Holmes	NULL
(	NULL
26	NULL
)	NULL
was	NULL
used	NULL
.	NULL

One	NULL
milliliter	NULL
of	NULL
fresh	NULL
incubation	NULL
media	NULL
containing	NULL
tritiated	NULL
vitamin	NULL
D	NULL
metabolites	NULL
was	NULL
added	NULL
to	NULL
adherent	NULL
cells	NULL
.	NULL

To	NULL
prepare	NULL
this	NULL
media	NULL
,	NULL
an	NULL
ethanolic	NULL
solution	NULL
of	NULL
[	NULL
°H	NULL
]	NULL
1,25	NULL
(	NULL
0H	NULL
)	NULL
,	NULL
D	NULL
,	NULL
or	NULL
[	NULL
°H	NULL
]	NULL
25	NULL
(	NULL
OH	NULL
)	NULL
D	NULL
,	NULL
was	NULL
added	NULL
to	NULL
rapidly	NULL
vortexed	NULL
media	NULL
to	NULL
minimize	NULL
the	NULL
loss	NULL
of	NULL
vitamin	NULL
D	NULL
metabolites	NULL
to	NULL
glassware	NULL
and	NULL
culture	NULL
dishes	NULL
.	NULL

Total	NULL
concentration	NULL
of	NULL
ethanol	NULL
was	NULL
less	NULL
than	NULL
0.1	NULL
%	NULL
,	NULL
and	NULL
final	NULL
concentrations	NULL
of	NULL
[	NULL
°H	NULL
]	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
and	NULL
[	NULL
°H	NULL
]	NULL
25	NULL
(	NULL
OH	NULL
)	NULL
D	NULL
,	NULL
were	NULL
0.26	NULL
nM	NULL
and	NULL
0.78	NULL
nM	NULL
,	NULL
respectively	NULL
.	NULL

Preliminary	NULL
experiments	NULL
demonstrated	NULL
that	NULL
total	NULL
cellular	NULL
uptake	NULL
of	NULL
1,25	NULL
(	NULL
O0H	NULL
)	NULL
;	NULL
D	NULL
,	NULL
and	NULL
25	NULL
(	NULL
OH	NULL
)	NULL
D	NULL
,	NULL
reached	NULL
a	NULL
plateau	NULL
after	NULL
a	NULL
30-min	NULL
incubation	NULL
.	NULL

Total	NULL
cellular	NULL
uptake	NULL
of	NULL
both	NULL
sterols	NULL
was	NULL
measured	NULL
in	NULL
untreated	NULL
and	NULL
colchicine-treated	NULL
(	NULL
750	NULL
uM	NULL
for	NULL
30	NULL
min	NULL
)	NULL
monocytes	NULL
.	NULL

After	NULL
a	NULL
1-h	NULL
incubation	NULL
of	NULL
monocytes	NULL
at	NULL
4	NULL
or	NULL
37°C	NULL
with	NULL
tritiated	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
or	NULL
25	NULL
(	NULL
OH	NULL
)	NULL
D	NULL
,	NULL
,	NULL
medium	NULL
was	NULL
removed	NULL
and	NULL
cells	NULL
were	NULL
washed	NULL
three	NULL
times	NULL
with	NULL
ice-cold	NULL
PBS	NULL
and	NULL
lysed	NULL
with	NULL
0.1	NULL
M	NULL
NaOH	NULL
.	NULL

Cell-associ-ated	NULL
[	NULL
°H	NULL
]	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
and	NULL
[	NULL
°HJ25	NULL
(	NULL
OH	NULL
)	NULL
D	NULL
,	NULL
,	NULL
were	NULL
measured	NULL
after	NULL
neutralization	NULL
with	NULL
1	NULL
M	NULL
HCl	NULL
Determinations	NULL
were	NULL
performed	NULL
in	NULL
triplicate	NULL
.	NULL

Results	NULL
were	NULL
expressed	NULL
as	NULL
femtomoles/ug	NULL
of	NULL
DNA/h	NULL
.	NULL

Immunofluorescence	NULL
Staining	NULL
for	NULL
o-Tubulin-Peripheral	NULL
blood	NULL
mononuclear	NULL
leukocytes	NULL
were	NULL
plated	NULL
on	NULL
coverslips	NULL
in	NULL
six-well	NULL
plates	NULL
following	NULL
the	NULL
protocols	NULL
described	NULL
for	NULL
monocyte	NULL
isolation	NULL
.	NULL

Adherent	NULL
cells	NULL
were	NULL
exposed	NULL
to	NULL
0	NULL
,	NULL
10	NULL
,	NULL
25	NULL
,	NULL
or	NULL
750	NULL
uM	NULL
colchicine	NULL
for	NULL
30	NULL
min	NULL
at	NULL
37	NULL
°C	NULL
.	NULL

Cells	NULL
were	NULL
washed	NULL
twice	NULL
with	NULL
PBS	NULL
and	NULL
incubated	NULL
in	NULL
fresh	NULL
RPMI	NULL
1640	NULL
containing	NULL
1	NULL
%	NULL
fatty-acid-free	NULL
albumin	NULL
until	NULL
fixation	NULL
.	NULL

For	NULL
nocodazole	NULL
treat-ment	NULL
,	NULL
monocytes	NULL
were	NULL
exposed	NULL
to	NULL
0	NULL
or	NULL
10	NULL
uM	NULL
nocodazole	NULL
for	NULL
30	NULL
min	NULL
at	NULL
37	NULL
°C	NULL
and	NULL
remained	NULL
in	NULL
contact	NULL
with	NULL
nocodazole	NULL
until	NULL
fixation	NULL
.	NULL

Cells	NULL
were	NULL
fixed	NULL
in	NULL
paraformaldehyde	NULL
(	NULL
4	NULL
%	NULL
)	NULL
for	NULL
20	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
,	NULL
washed	NULL
three	NULL
times	NULL
(	NULL
2	NULL
%	NULL
gelatin	NULL
in	NULL
phosphate-buffered	NULL
saline	NULL
)	NULL
,	NULL
incubated	NULL
for	NULL
20	NULL
min	NULL
with	NULL
blocking	NULL
buffer	NULL
(	NULL
0.1	NULL
1	NULL
NH	NULL
,	NULL
Cl	NULL
,	NULL
0.2	NULL
%	NULL
gelatin	NULL
,	NULL
0.05	NULL
%	NULL
Triton	NULL
X-100	NULL
)	NULL
,	NULL
and	NULL
stained	NULL
for	NULL
«	NULL
-tubulin	NULL
using	NULL
a	NULL
1:1000	NULL
dilution	NULL
of	NULL
a	NULL
monoclonal	NULL
mouse	NULL
anti-	NULL
«	NULL
-tubulin	NULL
(	NULL
Sigma	NULL
)	NULL
.	NULL

After	NULL
a	NULL
2	NULL
%	NULL
4-h	NULL
incubation	NULL
at	NULL
room	NULL
temperature	NULL
,	NULL
monocytes	NULL
were	NULL
washed	NULL
and	NULL
incubated	NULL
for	NULL
1	NULL
h	NULL
at	NULL
room	NULL
temperature	NULL
in	NULL
the	NULL
dark	NULL
with	NULL
fluorescein	NULL
isothiocyanate	NULL
goat-anti-mouse	NULL
IgG	NULL
(	NULL
1:100	NULL
)	NULL
(	NULL
Cappel	NULL
)	NULL
.	NULL

Antibodies	NULL
were	NULL
diluted	NULL
with	NULL
washing	NULL
buffer	NULL
containing	NULL
30	NULL
%	NULL
goat	NULL
serum	NULL
.	NULL

After	NULL
mounting	NULL
with	NULL
50	NULL
%	NULL
glycerol	NULL
in	NULL
PBS	NULL
,	NULL
cells	NULL
were	NULL
examined	NULL
for	NULL
microtubular	NULL
assembly	NULL
using	NULL
confocal	NULL
microscopy	NULL
.	NULL

A	NULL
minimum	NULL
of	NULL
50	NULL
cells	NULL
were	NULL
scored	NULL
for	NULL
each	NULL
experimental	NULL
condition	NULL
.	NULL

Monocytes	NULL
containing	NULL
one	NULL
or	NULL
more	NULL
filament-like	NULL
structures	NULL
were	NULL
considered	NULL
positive	NULL
for	NULL
polymerized	NULL
tubulin	NULL
and	NULL
not	NULL
completely	NULL
disrupted	NULL
.	NULL

Maximal	NULL
Specific	NULL
Binding	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
to	NULL
VDR-Adhkerent	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
or	NULL
without	NULL
colchicine	NULL
(	NULL
750	NULL
um	NULL
for	NULL
30	NULL
min	NULL
at	NULL
37	NULL
°C	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
then	NULL
washed	NULL
and	NULL
incubated	NULL
with	NULL
0.5	NULL
nm	NULL
[	NULL
°H	NULL
]	NULL
1,25	NULL
(	NULL
O0H	NULL
)	NULL
,	NULL
D	NULL
;	NULL
with	NULL
(	NULL
nonspecific	NULL
binding	NULL
)	NULL
and	NULL
without	NULL
125	NULL
nM	NULL
radioinert	NULL
1,25	NULL
(	NULL
0H	NULL
)	NULL
,	NULL
D	NULL
;	NULL
for	NULL
2	NULL
h.	NULL
Cells	NULL
were	NULL
rinsed	NULL
once	NULL
with	NULL
PBS	NULL
containing	NULL
5	NULL
mg/m	NULL
!	NULL

fatty-acid-	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
22162	NULL
free	NULL
albumin	NULL
,	NULL
then	NULL
twice	NULL
with	NULL
PBS	NULL
alone	NULL
and	NULL
placed	NULL
on	NULL
ice	NULL
.	NULL

After	NULL
the	NULL
addition	NULL
of	NULL
2	NULL
ml	NULL
of	NULL
TEDK	NULL
(	NULL
10	NULL
my	NULL
Tris-HCl	NULL
,	NULL
pH	NULL
7.4	NULL
,	NULL
1.5	NULL
mm	NULL
EDTA	NULL
,	NULL
400	NULL
mM	NULL
KCl	NULL
,	NULL
and	NULL
5	NULL
mM	NULL
dithiothreitol	NULL
)	NULL
,	NULL
the	NULL
contents	NULL
of	NULL
each	NULL
well	NULL
were	NULL
sonicated	NULL
for	NULL
30	NULL
s.	NULL
Samples	NULL
were	NULL
transferred	NULL
to	NULL
small	NULL
tubes	NULL
,	NULL
and	NULL
500	NULL
ul	NULL
of	NULL
charcoal	NULL
was	NULL
added	NULL
.	NULL

Tubes	NULL
were	NULL
kept	NULL
on	NULL
ice	NULL
for	NULL
15	NULL
min	NULL
and	NULL
centrifuged	NULL
at	NULL
2500	NULL
rpm	NULL
for	NULL
15	NULL
min	NULL
.	NULL

Aliquots	NULL
(	NULL
0.5	NULL
ml	NULL
)	NULL
of	NULL
the	NULL
supernatant	NULL
were	NULL
mixed	NULL
with	NULL
4.5	NULL
ml	NULL
of	NULL
scintillation	NULL
fluid	NULL
and	NULL
counted	NULL
for	NULL
tritium	NULL
.	NULL

Results	NULL
are	NULL
expressed	NULL
as	NULL
femtomoles	NULL
of	NULL
1,25	NULL
(	NULL
O0H	NULL
)	NULL
,	NULL
D	NULL
,	NULL
/ug	NULL
of	NULL
DNA	NULL
.	NULL

Subcellular	NULL
25	NULL
(	NULL
OH	NULL
)	NULL
D	NULL
,	NULL
,	NULL
Uptake-Subcellular	NULL
uptake	NULL
of	NULL
25	NULL
(	NULL
OH	NULL
)	NULL
D	NULL
,	NULL
was	NULL
measured	NULL
using	NULL
a	NULL
modification	NULL
of	NULL
the	NULL
procedure	NULL
described	NULL
by	NULL
Shany	NULL
ef	NULL
al	NULL
.	NULL

(	NULL
27	NULL
)	NULL
.	NULL

Adherent	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
or	NULL
without	NULL
colchicine	NULL
(	NULL
10	NULL
and	NULL
750	NULL
um	NULL
)	NULL
.	NULL

After	NULL
a	NULL
30-min	NULL
incubation	NULL
at	NULL
37	NULL
°C	NULL
,	NULL
cells	NULL
were	NULL
washed	NULL
and	NULL
incubated	NULL
at	NULL
37°C	NULL
for	NULL
1	NULL
h	NULL
in	NULL
1	NULL
ml	NULL
of	NULL
RPMI	NULL
1640	NULL
containing	NULL
0.1	NULL
%	NULL
fatty-acid-free	NULL
albumin	NULL
,	NULL
0.1	NULL
wCi	NULL
of	NULL
[	NULL
°H	NULL
]	NULL
25	NULL
(	NULL
OH	NULL
)	NULL
D	NULL
;	NULL
,	NULL
and	NULL
10	NULL
uM	NULL
ketocon-azole	NULL
,	NULL
a	NULL
cytochrome	NULL
P-450	NULL
inhibitor	NULL
,	NULL
to	NULL
block	NULL
25	NULL
(	NULL
OH	NULL
)	NULL
D	NULL
,	NULL
metabolism	NULL
.	NULL

Cells	NULL
were	NULL
rinsed	NULL
once	NULL
with	NULL
phosphate-buffered	NULL
saline	NULL
and	NULL
twice	NULL
with	NULL
RPMI	NULL
1640	NULL
containing	NULL
0.1	NULL
%	NULL
fatty	NULL
acid-free	NULL
albumin	NULL
.	NULL

Monocytes	NULL
were	NULL
disrupted	NULL
by	NULL
sonication	NULL
in	NULL
1	NULL
ml	NULL
of	NULL
TMSS	NULL
buffer	NULL
,	NULL
pH	NULL
7.4	NULL
(	NULL
15	NULL
mM	NULL
Tris	NULL
acetate	NULL
,	NULL
2	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
2.5	NULL
mM	NULL
succinate	NULL
,	NULL
and	NULL
250	NULL
mM	NULL
sucrose	NULL
)	NULL
containing	NULL
phenylmethylsulfonyl	NULL
fluoride	NULL
(	NULL
10	NULL
pM	NULL
)	NULL
.	NULL

Fifteen	NULL
wells	NULL
of	NULL
untreated	NULL
and	NULL
colchicine-treated	NULL
sonicated	NULL
monocytes	NULL
were	NULL
pooled	NULL
in	NULL
50-ml	NULL
culture	NULL
tubes	NULL
,	NULL
and	NULL
final	NULL
volumes	NULL
were	NULL
measured	NULL
.	NULL

0.5	NULL
ml	NULL
of	NULL
these	NULL
samples	NULL
were	NULL
counted	NULL
for	NULL
tritium	NULL
,	NULL
and	NULL
total	NULL
tritium	NULL
in	NULL
whole	NULL
cell	NULL
homogenates	NULL
was	NULL
calculated	NULL
.	NULL

For	NULL
subcellular	NULL
fractionation	NULL
,	NULL
homogenates	NULL
were	NULL
divided	NULL
in	NULL
4	NULL
aliquots	NULL
of	NULL
equal	NULL
volume	NULL
.	NULL

Aliquots	NULL
were	NULL
centrifuged	NULL
at	NULL
700	NULL
X	NULL
g	NULL
for	NULL
10	NULL
min	NULL
at	NULL
4	NULL
°C	NULL
.	NULL

The	NULL
supernatants	NULL
were	NULL
centrifuged	NULL
at	NULL
8500	NULL
%	NULL
g	NULL
for	NULL
10	NULL
min	NULL
at	NULL
4	NULL
°C	NULL
.	NULL

Resultant	NULL
supernatants	NULL
were	NULL
centrifuged	NULL
at	NULL
10,000	NULL
x	NULL
g	NULL
for	NULL
10	NULL
min	NULL
at	NULL
4	NULL
°C	NULL
.	NULL

Final	NULL
supernatants	NULL
were	NULL
centrifuged	NULL
at	NULL
100,000	NULL
x	NULL
g	NULL
for	NULL
1	NULL
h	NULL
at	NULL
4	NULL
°C	NULL
.	NULL

The	NULL
resultant	NULL
pellets	NULL
(	NULL
700	NULL
x	NULL
g	NULL
,	NULL
containing	NULL
mainly	NULL
nuclei	NULL
and	NULL
cellular	NULL
membranes	NULL
;	NULL
8,500	NULL
x	NULL
g	NULL
,	NULL
mainly	NULL
mitochondrial	NULL
fraction	NULL
;	NULL
10,000	NULL
%	NULL
g	NULL
,	NULL
residual	NULL
mitochondrial	NULL
fraction	NULL
;	NULL
100,000	NULL
x	NULL
g	NULL
,	NULL
mainly	NULL
microsomal	NULL
fraction	NULL
)	NULL
were	NULL
resuspended	NULL
in	NULL
0.5	NULL
ml	NULL
of	NULL
ethanol	NULL
,	NULL
vortexed	NULL
,	NULL
and	NULL
transferred	NULL
to	NULL
mini	NULL
scintillation	NULL
vials	NULL
.	NULL

Potential	NULL
residual	NULL
pellets	NULL
were	NULL
washed	NULL
three	NULL
times	NULL
in	NULL
1	NULL
ml	NULL
of	NULL
hexane	NULL
:	NULL
isopropyl	NULL
alcohol	NULL
(	NULL
95:5	NULL
)	NULL
and	NULL
pooled	NULL
with	NULL
the	NULL
ethanol	NULL
fraction	NULL
.	NULL

Organic	NULL
solvents	NULL
were	NULL
air-dried	NULL
at	NULL
room	NULL
temperature	NULL
,	NULL
and	NULL
the	NULL
amount	NULL
of	NULL
tritium	NULL
associated	NULL
to	NULL
each	NULL
subcellular	NULL
fraction	NULL
was	NULL
counted	NULL
.	NULL

To	NULL
assess	NULL
the	NULL
purity	NULL
of	NULL
the	NULL
subcellular	NULL
fractions	NULL
,	NULL
we	NULL
assayed	NULL
succinic	NULL
dehydrogenase	NULL
(	NULL
28	NULL
)	NULL
and	NULL
NADPH-cytochrome	NULL
c	NULL
reductase	NULL
(	NULL
29	NULL
)	NULL
activities	NULL
as	NULL
mitochondrial	NULL
and	NULL
microsomal	NULL
specific	NULL
markers	NULL
,	NULL
respectively	NULL
.	NULL

Results	NULL
were	NULL
expressed	NULL
as	NULL
percent	NULL
of	NULL
total	NULL
enzymatic	NULL
activity	NULL
in	NULL
each	NULL
subcellular	NULL
fraction	NULL
.	NULL

K	NULL
,	NULL
,	NULL
and	NULL
V.	NULL
,	NULL
,	NULL
Determinations-Four	NULL
different	NULL
substrate	NULL
concentrations	NULL
(	NULL
from	NULL
5	NULL
to	NULL
300	NULL
nM	NULL
)	NULL
of	NULL
25	NULL
(	NULL
OH	NULL
)	NULL
D	NULL
,	NULL
were	NULL
assayed	NULL
in	NULL
triplicate	NULL
to	NULL
measure	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
;	NULL
,	NULL
synthesis	NULL
.	NULL

K	NULL
,	NULL
,	NULL
,	NULL
and	NULL
V	NULL
,	NULL
,	NULL
,	NULL
,	NULL
were	NULL
obtained	NULL
from	NULL
a	NULL
linear	NULL
regression	NULL
analysis	NULL
of	NULL
the	NULL
data	NULL
using	NULL
the	NULL
double	NULL
reciprocal	NULL
plot	NULL
of	NULL
Lineweaver-Burk	NULL
.	NULL

Subcellular	NULL
Localization	NULL
of	NULL
Monocyte	NULL
1	NULL
«	NULL
-Hydroxylase-Monocytes	NULL
were	NULL
incubated	NULL
with	NULL
or	NULL
without	NULL
10	NULL
or	NULL
750	NULL
uM	NULL
colchicine	NULL
for	NULL
30	NULL
min	NULL
.	NULL

Mitochondrial	NULL
and	NULL
microsomal	NULL
fractions	NULL
obtained	NULL
as	NULL
indicated	NULL
above	NULL
were	NULL
incubated	NULL
with	NULL
2	NULL
mM	NULL
isocitrate	NULL
and	NULL
1	NULL
mm	NULL
NADPH	NULL
,	NULL
respectively	NULL
,	NULL
at	NULL
37°C	NULL
,	NULL
in	NULL
an	NULL
atmosphere	NULL
containing	NULL
95	NULL
%	NULL
air	NULL
,	NULL
5	NULL
%	NULL
CO	NULL
,	NULL
,	NULL
for	NULL
1	NULL
h.	NULL
The	NULL
reaction	NULL
was	NULL
initiated	NULL
by	NULL
adding	NULL
5.0	NULL
nm	NULL
[	NULL
°H	NULL
]	NULL
J25	NULL
(	NULL
OH	NULL
)	NULL
D	NULL
;	NULL
dissolved	NULL
in	NULL
200	NULL
pl	NULL
of	NULL
the	NULL
same	NULL
buffer	NULL
containing	NULL
5	NULL
mg/ml	NULL
albumin	NULL
.	NULL

The	NULL
final	NULL
assay	NULL
incubation	NULL
volume	NULL
was	NULL
1	NULL
ml	NULL
.	NULL

The	NULL
reactions	NULL
were	NULL
stopped	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
1	NULL
ml	NULL
of	NULL
acetonitrile	NULL
.	NULL

100	NULL
ng	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
;	NULL
D	NULL
;	NULL
,	NULL
was	NULL
added	NULL
to	NULL
monitor	NULL
recovery	NULL
,	NULL
and	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
production	NULL
was	NULL
measured	NULL
as	NULL
indicated	NULL
above	NULL
.	NULL

Results	NULL
are	NULL
expressed	NULL
as	NULL
femtomoles	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
/ug	NULL
of	NULL
total	NULL
cell	NULL
DNA/h	NULL
.	NULL

Statistical	NULL
Analysis-Statistical	NULL
evaluation	NULL
of	NULL
the	NULL
data	NULL
was	NULL
performed	NULL
using	NULL
Student	NULL
's	NULL
¢	NULL
test	NULL
for	NULL
unpaired	NULL
observations	NULL
.	NULL

RESULTS	NULL
Effect	NULL
of	NULL
Microtubule	NULL
Disruption	NULL
on	NULL
the	NULL
Response	NULL
of	NULL
Normal	NULL
Human	NULL
Monocytes	NULL
to	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
,	NULL
D	NULL
;	NULL
-We	NULL
examined	NULL
the	NULL
effect	NULL
of	NULL
disruption	NULL
of	NULL
microtubular	NULL
assembly	NULL
on	NULL
the	NULL
ability	NULL
of	NULL
1,25	NULL
(	NULL
O0H	NULL
)	NULL
,	NULL
;	NULL
D	NULL
;	NULL
to	NULL
suppress	NULL
its	NULL
own	NULL
production	NULL
and	NULL
to	NULL
induce	NULL
vitamin	NULL
D	NULL
catabolism	NULL
.	NULL

Fig	NULL
.	NULL

1	NULL
shows	NULL
that	NULL
,	NULL
in	NULL
normal	NULL
human	NULL
monocytes	NULL
,	NULL
the	NULL
ability	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
to	NULL
inhibit	NULL
its	NULL
own	NULL
synthesis	NULL
is	NULL
impaired	NULL
by	NULL
colchicine	NULL
in	NULL
a	NULL
dose-dependent	NULL
manner	NULL
.	NULL

At	NULL
a	NULL
concentration	NULL
of	NULL
colchicine	NULL
of	NULL
25	NULL
um	NULL
,	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
was	NULL
no	NULL
longer	NULL
able	NULL
to	NULL
suppress	NULL
monocyte	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
production	NULL
.	NULL

The	NULL
number	NULL
of	NULL
monocytes	NULL
that	NULL
stained	NULL
positive	NULL
for	NULL
polymerized	NULL
tubulin	NULL
decreased	NULL
from	NULL
91	NULL
%	NULL
in	NULL
control	NULL
preparations	NULL
to	NULL
62	NULL
,	NULL
22	NULL
,	NULL
and	NULL
9	NULL
%	NULL
after	NULL
a	NULL
30-min	NULL
exposure	NULL
to	NULL
concentrations	NULL
of	NULL
colchicine	NULL
of	NULL
10	NULL
,	NULL
25	NULL
,	NULL
and	NULL
750	NULL
um	NULL
,	NULL
respectively	NULL
.	NULL

Role	NULL
of	NULL
Microtubules	NULL
in	NULL
Vitamin	NULL
D	NULL
Transport	NULL
and	NULL
Action	NULL
2.0	NULL
-	NULL
0.05	NULL
[	NULL
-	NULL
]	NULL
Vehicle	NULL
Sy	NULL
1,25	NULL
(	NULL
0M	NULL
)	NULL
,	NULL
D	NULL
;	NULL
,	NULL
1.0	NULL
|	NULL
A	NULL
&	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
,	NULL
synthesis	NULL
(	NULL
fmol	NULL
/	NULL
pg	NULL
DNA	NULL
h	NULL
)	NULL
ooo	NULL
LMT	NULL
4	NULL
gﬁj	NULL
in	NULL
tr	NULL
7	NULL
0.0	NULL
_|	NULL
SS	NULL
$	NULL
BS	NULL
0	NULL
10	NULL
25	NULL
250	NULL
500	NULL
750	NULL
Colchicine	NULL
(	NULL
M	NULL
)	NULL
6	NULL
S	NULL
Fic	NULL
.	NULL

1	NULL
.	NULL

Dose-dependent	NULL
effect	NULL
of	NULL
colchicine	NULL
on	NULL
the	NULL
suppression	NULL
of	NULL
1,25	NULL
(	NULL
0H	NULL
)	NULL
,	NULL
D	NULL
,	NULL
synthesis	NULL
by	NULL
exogenous	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
.	NULL

Adherent	NULL
cells	NULL
were	NULL
incubated	NULL
in	NULL
serum-free	NULL
media	NULL
with	NULL
doses	NULL
of	NULL
colchicine	NULL
from	NULL
0	NULL
to	NULL
750	NULL
px	NULL
for	NULL
30	NULL
min	NULL
.	NULL

Media	NULL
were	NULL
removed	NULL
,	NULL
and	NULL
cells	NULL
were	NULL
washed	NULL
and	NULL
incubated	NULL
with	NULL
0	NULL
(	NULL
vehicle	NULL
)	NULL
or	NULL
0.24	NULL
nm	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
;	NULL
for	NULL
4	NULL
h.	NULL
Synthesis	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
,	NULL
was	NULL
measured	NULL
as	NULL
outlined	NULL
under	NULL
``	NULL
Experimental	NULL
Procedures	NULL
.	NULL
``	NULL

Results	NULL
are	NULL
expressed	NULL
as	NULL
femtomoles/ug	NULL
of	NULL
DNA/h	NULL
.	NULL

Values	NULL
are	NULL
mean	NULL
+	NULL
S.E	NULL
.	NULL

of	NULL
five	NULL
independent	NULL
experiments	NULL
performed	NULL
in	NULL
triplicate	NULL
(	NULL
*	NULL
,	NULL
differs	NULL
from	NULL
control	NULL
,	NULL
p	NULL
=	NULL
0.05	NULL
)	NULL
.	NULL

Because	NULL
colchicine	NULL
alone	NULL
caused	NULL
a	NULL
dose-dependent	NULL
reduction	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
,	NULL
production	NULL
by	NULL
monocytes	NULL
,	NULL
we	NULL
performed	NULL
the	NULL
experiments	NULL
summarized	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
to	NULL
define	NULL
the	NULL
effects	NULL
of	NULL
microtubule	NULL
disruption	NULL
in	NULL
the	NULL
response	NULL
of	NULL
monocytes	NULL
to	NULL
1,25	NULL
(	NULL
0H	NULL
)	NULL
,	NULL
D	NULL
;	NULL
.	NULL

The	NULL
lowest	NULL
(	NULL
25	NULL
um	NULL
)	NULL
and	NULL
highest	NULL
(	NULL
750	NULL
um	NULL
)	NULL
doses	NULL
of	NULL
colchicine	NULL
,	NULL
effective	NULL
in	NULL
blocking	NULL
the	NULL
ability	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
,	NULL
D	NULL
;	NULL
to	NULL
suppress	NULL
its	NULL
own	NULL
production	NULL
,	NULL
were	NULL
used	NULL
to	NULL
examine	NULL
the	NULL
effect	NULL
of	NULL
microtubule	NULL
disruption	NULL
on	NULL
the	NULL
ability	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
to	NULL
suppress	NULL
its	NULL
own	NULL
synthesis	NULL
(	NULL
upper	NULL
panel	NULL
)	NULL
and	NULL
to	NULL
induce	NULL
vitamin	NULL
D	NULL
catabolism	NULL
(	NULL
generation	NULL
of	NULL
24-hydroxylated	NULL
metabolites	NULL
more	NULL
polar	NULL
than	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
,	NULL
D	NULL
;	NULL
(	NULL
polar	NULL
metabolites	NULL
)	NULL
;	NULL
lower	NULL
panel	NULL
)	NULL
.	NULL

In	NULL
monocytes	NULL
with	NULL
intact	NULL
microtubules	NULL
(	NULL
Controls	NULL
)	NULL
,	NULL
exposure	NULL
to	NULL
0.24	NULL
nw	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
for	NULL
4	NULL
h	NULL
reduced	NULL
1,25	NULL
(	NULL
O0H	NULL
)	NULL
,	NULL
D	NULL
;	NULL
synthesis	NULL
to	NULL
55.2	NULL
+	NULL
1.3	NULL
%	NULL
and	NULL
increased	NULL
the	NULL
generation	NULL
of	NULL
polar	NULL
metabolites	NULL
7-fold	NULL
above	NULL
vehicle	NULL
controls	NULL
,	NULL
respectively	NULL
.	NULL

However	NULL
,	NULL
when	NULL
monocytes	NULL
were	NULL
treated	NULL
with	NULL
25	NULL
or	NULL
750	NULL
um	NULL
colchicine	NULL
for	NULL
30	NULL
min	NULL
before	NULL
exposure	NULL
to	NULL
0	NULL
(	NULL
vehicle	NULL
)	NULL
or	NULL
0.24	NULL
nm	NULL
1,25	NULL
(	NULL
O0H	NULL
)	NULL
;	NULL
,	NULL
D	NULL
;	NULL
for	NULL
4	NULL
h	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
Pre	NULL
)	NULL
exogenous	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
,	NULL
D	NULL
;	NULL
could	NULL
no	NULL
longer	NULL
reduce	NULL
1,25	NULL
(	NULL
O0H	NULL
)	NULL
,	NULL
D	NULL
;	NULL
,	NULL
synthesis	NULL
nor	NULL
enhance	NULL
the	NULL
production	NULL
of	NULL
polar	NULL
metabolites	NULL
.	NULL

As	NULL
mentioned	NULL
for	NULL
the	NULL
dose	NULL
response	NULL
to	NULL
colchicine	NULL
,	NULL
in	NULL
monocytes	NULL
exposed	NULL
to	NULL
colchicine	NULL
alone	NULL
(	NULL
vehicle	NULL
)	NULL
,	NULL
there	NULL
was	NULL
a	NULL
marked	NULL
reduction	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
synthesis	NULL
.	NULL

To	NULL
assess	NULL
whether	NULL
the	NULL
lack	NULL
of	NULL
response	NULL
to	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
,	NULL
D	NULL
;	NULL
with	NULL
colchicine	NULL
treatment	NULL
was	NULL
the	NULL
result	NULL
of	NULL
a	NULL
direct	NULL
effect	NULL
of	NULL
colchicine	NULL
on	NULL
monocyte	NULL
hydroxylases	NULL
rather	NULL
than	NULL
the	NULL
consequence	NULL
of	NULL
a	NULL
defective	NULL
access	NULL
of	NULL
the	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
-VDR	NULL
complex	NULL
to	NULL
the	NULL
nu-cleus	NULL
,	NULL
monocytes	NULL
were	NULL
first	NULL
incubated	NULL
with	NULL
0	NULL
(	NULL
vehicle	NULL
)	NULL
or	NULL
0.24	NULL
nm	NULL
1,25	NULL
(	NULL
0H	NULL
)	NULL
,	NULL
D	NULL
;	NULL
for	NULL
4	NULL
h	NULL
and	NULL
then	NULL
exposed	NULL
to	NULL
colchicine	NULL
for	NULL
30	NULL
min	NULL
.	NULL

Measurements	NULL
of	NULL
synthesis	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
and	NULL
polar	NULL
metabolites	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
Post	NULL
)	NULL
show	NULL
,	NULL
in	NULL
vehicle	NULL
controls	NULL
,	NULL
a	NULL
similar	NULL
decrease	NULL
in	NULL
la-hydroxylase	NULL
as	NULL
described	NULL
in	NULL
Pre	NULL
experiments	NULL
with	NULL
no	NULL
significant	NULL
changes	NULL
in	NULL
the	NULL
apparent	NULL
activity	NULL
of	NULL
the	NULL
hydroxylases	NULL
involved	NULL
in	NULL
vitamin	NULL
D	NULL
catabolism	NULL
.	NULL

However	NULL
,	NULL
in	NULL
these	NULL
protocols	NULL
,	NULL
microtubule	NULL
disruption	NULL
occurred	NULL
after	NULL
the	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
-VDR	NULL
complex	NULL
had	NULL
interacted	NULL
with	NULL
the	NULL
genome	NULL
,	NULL
and	NULL
,	NULL
despite	NULL
the	NULL
reduction	NULL
in	NULL
l1a-hydroxylase	NULL
activity	NULL
in	NULL
vehicle	NULL
control	NULL
monocytes	NULL
,	NULL
exogenous	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
could	NULL
reduce	NULL
its	NULL
own	NULL
synthesis	NULL
and	NULL
increase	NULL
vitamin	NULL
D	NULL
catabolism	NULL
with	NULL
a	NULL
potency	NULL
similar	NULL
to	NULL
that	NULL
observed	NULL
in	NULL
monocytes	NULL
with	NULL
intact	NULL
micro-tubules	NULL
.	NULL

Specifically	NULL
,	NULL
a	NULL
54.2	NULL
+	NULL
3.1	NULL
%	NULL
reduction	NULL
of	NULL
1,25	NULL
(	NULL
O0H	NULL
)	NULL
;	NULL
,	NULL
D	NULL
;	NULL
synthesis	NULL
and	NULL
743.2	NULL
+	NULL
24.1	NULL
%	NULL
induction	NULL
of	NULL
vitamin	NULL
D	NULL
catabolism	NULL
by	NULL
0.24	NULL
nw	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
,	NULL
was	NULL
observed	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
25	NULL
um	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
Role	NULL
of	NULL
Microtubules	NULL
in	NULL
Vitamin	NULL
D	NULL
Transport	NULL
and	NULL
Action	NULL
p	NULL
<	NULL
0.01	NULL
[	NULL
:	NULL
]	NULL
Vehicle	NULL
EW	NULL
1,25	NULL
(	NULL
0M	NULL
)	NULL
;	NULL
0	NULL
;	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
synthesis	NULL
(	NULL
fmal	NULL
/	NULL
jg	NULL
DNA	NULL
h	NULL
)	NULL
Control	NULL
Pre	NULL
Post	NULL
__	NULL
,	NULL
Pre	NULL
Post	NULL
25	NULL
pM	NULL
750	NULL
pM	NULL
Colchicine	NULL
3	NULL
8	NULL
Syntheals	NULL
of	NULL
polar	NULL
metabolites	NULL
(	NULL
fmal	NULL
/	NULL
pg	NULL
DNA	NULL
-	NULL
h	NULL
)	NULL
B	NULL
Colchicine	NULL
Fic	NULL
.	NULL

2	NULL
.	NULL

Effect	NULL
of	NULL
colchicine	NULL
on	NULL
the	NULL
suppression	NULL
of	NULL
1,25	NULL
(	NULL
0H	NULL
)	NULL
,	NULL
D	NULL
,	NULL
synthesis	NULL
and	NULL
induction	NULL
of	NULL
vitamin	NULL
D	NULL
catabolism	NULL
by	NULL
exogenous	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
.	NULL

Pre	NULL
,	NULL
adherent	NULL
cells	NULL
were	NULL
incubated	NULL
in	NULL
serum-free	NULL
media	NULL
with	NULL
0	NULL
(	NULL
Control	NULL
)	NULL
,	NULL
25	NULL
,	NULL
or	NULL
750	NULL
uM	NULL
colchicine	NULL
for	NULL
30	NULL
min	NULL
.	NULL

Media	NULL
were	NULL
removed	NULL
,	NULL
and	NULL
cells	NULL
were	NULL
washed	NULL
and	NULL
incubated	NULL
with	NULL
0	NULL
(	NULL
vehicle	NULL
)	NULL
or	NULL
0.24	NULL
nM	NULL
1,25	NULL
(	NULL
O0H	NULL
)	NULL
,	NULL
D	NULL
;	NULL
for	NULL
4	NULL
h.	NULL
Post	NULL
,	NULL
cells	NULL
were	NULL
exposed	NULL
to	NULL
0	NULL
or	NULL
0.24	NULL
nM	NULL
1,25	NULL
(	NULL
O0H	NULL
)	NULL
,	NULL
D	NULL
;	NULL
,	NULL
for	NULL
4	NULL
h	NULL
and	NULL
then	NULL
were	NULL
incubated	NULL
with	NULL
25	NULL
or	NULL
750	NULL
uM	NULL
colchicine	NULL
for	NULL
30	NULL
min	NULL
.	NULL

Synthesis	NULL
of	NULL
1,25	NULL
(	NULL
0H	NULL
)	NULL
,	NULL
D	NULL
,	NULL
(	NULL
4	NULL
)	NULL
and	NULL
polar	NULL
metabolites	NULL
(	NULL
B	NULL
)	NULL
was	NULL
measured	NULL
as	NULL
outlined	NULL
under	NULL
``	NULL
Experimental	NULL
Procedures	NULL
.	NULL
``	NULL

Results	NULL
are	NULL
expressed	NULL
as	NULL
femtomoles/pg	NULL
of	NULL
DNA/h	NULL
.	NULL

Values	NULL
are	NULL
mean	NULL
+	NULL
S.E	NULL
.	NULL

of	NULL
three	NULL
independent	NULL
experiments	NULL
performed	NULL
in	NULL
triplicate	NULL
.	NULL

colchicine	NULL
,	NULL
and	NULL
52.1	NULL
+	NULL
3.1	NULL
%	NULL
and	NULL
701.2	NULL
+	NULL
24.2	NULL
%	NULL
,	NULL
respectively	NULL
,	NULL
with	NULL
750	NULL
um	NULL
colchicine	NULL
.	NULL

Similar	NULL
blockage	NULL
of	NULL
the	NULL
ability	NULL
of	NULL
exogenous	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
to	NULL
control	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
production	NULL
and	NULL
vitamin	NULL
D	NULL
catabolism	NULL
by	NULL
monocytes	NULL
was	NULL
observed	NULL
with	NULL
another	NULL
microtubule	NULL
disrupting	NULL
agent	NULL
,	NULL
vinblastine	NULL
,	NULL
at	NULL
50	NULL
and	NULL
100	NULL
um	NULL
concentrations	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
results	NULL
demonstrate	NULL
that	NULL
microtubular	NULL
integrity	NULL
is	NULL
required	NULL
for	NULL
monocytes	NULL
to	NULL
respond	NULL
to	NULL
1,25	NULL
(	NULL
O0H	NULL
)	NULL
,	NULL
D	NULL
;	NULL
.	NULL

Further	NULL
support	NULL
for	NULL
these	NULL
findings	NULL
came	NULL
from	NULL
measurements	NULL
of	NULL
steady	NULL
state	NULL
levels	NULL
of	NULL
24-hydroxylase	NULL
mRNA	NULL
using	NULL
a	NULL
ribonuclease	NULL
protection	NULL
assay	NULL
.	NULL

Fig	NULL
.	NULL

3	NULL
shows	NULL
that	NULL
intact	NULL
monocytes	NULL
responded	NULL
to	NULL
physiological	NULL
concentrations	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
,	NULL
with	NULL
a	NULL
marked	NULL
induction	NULL
of	NULL
24-hydroxylase	NULL
mRNA	NULL
.	NULL

However	NULL
,	NULL
pretreatment	NULL
of	NULL
monocytes	NULL
with	NULL
colchicine	NULL
impaired	NULL
the	NULL
ability	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
to	NULL
induce	NULL
24-hydroxylase	NULL
gene	NULL
transcription	NULL
in	NULL
a	NULL
dose-dependent	NULL
manner	NULL
.	NULL

A	NULL
partial	NULL
reduction	NULL
of	NULL
24-hydroxylase	NULL
mRNA	NULL
levels	NULL
was	NULL
achieved	NULL
with	NULL
10	NULL
um	NULL
colchicine	NULL
and	NULL
,	NULL
similar	NULL
to	NULL
the	NULL
increase	NULL
in	NULL
the	NULL
synthesis	NULL
of	NULL
polar	NULL
metabolites	NULL
,	NULL
25	NULL
ux	NULL
colchicine	NULL
caused	NULL
total	NULL
inhibition	NULL
of	NULL
the	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
-mediated	NULL
increase	NULL
in	NULL
24-hydroxylase	NULL
mRNA	NULL
.	NULL

When	NULL
the	NULL
30-min	NULL
treatment	NULL
with	NULL
colchicine	NULL
(	NULL
10	NULL
,	NULL
25	NULL
,	NULL
and	NULL
750	NULL
um	NULL
)	NULL
followed	NULL
the	NULL
4-h	NULL
exposure	NULL
to	NULL
0.24	NULL
nm	NULL
1,25	NULL
(	NULL
0H	NULL
)	NULL
;	NULL
,	NULL
D	NULL
;	NULL
,	NULL
the	NULL
increase	NULL
in	NULL
24-hydroxylase	NULL
mRNA	NULL
levels	NULL
was	NULL
identical	NULL
with	NULL
that	NULL
observed	NULL
in	NULL
monocytes	NULL
exposed	NULL
to	NULL
1,25	NULL
(	NULL
O0H	NULL
)	NULL
,	NULL
D	NULL
;	NULL
alone	NULL
.	NULL

This	NULL
suggests	NULL
that	NULL
a	NULL
30-min	NULL
exposure	NULL
to	NULL
colchicine	NULL
has	NULL
no	NULL
significant	NULL
direct	NULL
effect	NULL
either	NULL
in	NULL
mRNA	NULL
stability	NULL
or	NULL
in	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
-mediated	NULL
transcription	NULL
.	NULL

To	NULL
confirm	NULL
that	NULL
the	NULL
effects	NULL
of	NULL
colchicine	NULL
on	NULL
the	NULL
genomic	NULL
action	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
,	NULL
D	NULL
;	NULL
in	NULL
monocytes	NULL
were	NULL
mediated	NULL
by	NULL
microtubule	NULL
disruption	NULL
only	NULL
,	NULL
we	NULL
performed	NULL
similar	NULL
experiments	NULL
with	NULL
nocodazole	NULL
,	NULL
a	NULL
reversible	NULL
microtubule	NULL
disrupting	NULL
agent	NULL
.	NULL

Fig	NULL
.	NULL

4	NULL
shows	NULL
A	NULL
24-hnydroxylase-	NULL
»	NULL
f	NULL
Su	NULL
GAPDH	NULL
-	NULL
»	NULL
»	NULL
|	NULL
aus	NULL
aus	NULL
us	NULL
ag	NULL
wan	NULL
wah	NULL
mah	NULL
as	NULL
on	NULL
Milk	NULL
I	NULL
|	NULL
aas	NULL
Wie	NULL
6+	NULL
Cit	NULL
ws	NULL
OJ	NULL
125	NULL
(	NULL
0MpD	NULL
,	NULL
t	NULL
-	NULL
tk	NULL
4+	NULL
+	NULL
+	NULL
+	NULL
+	NULL
t	NULL
+o	NULL
+	NULL
-on	NULL
+	NULL
+	NULL
-	NULL
>	NULL
4	NULL
4	NULL
+++	NULL
LU	NULL
L	NULL
LGP	NULL
LG	NULL
LJ	NULL
LJ	NULL
L_	NULL
Pre	NULL
Post	NULL
Pre	NULL
Post	NULL
Pre	NULL
Pre	NULL
-	NULL
Post	NULL
coum	NULL
?	NULL

_	NULL
Laspm	NULL
?	NULL

!	NULL

-	NULL
750	NULL
pM	NULL
--	NULL
-	NULL
Calchicine	NULL
-	NULL
Colchicine	NULL
B	NULL
0.2	NULL
T	NULL
o	NULL
a	NULL
.	NULL

<	NULL
G	NULL
~	NULL
P	NULL
a	NULL
S	NULL
01-	NULL
>	NULL
x	NULL
2	NULL
o	NULL
>	NULL
ick	NULL
<	NULL
bl	NULL
0.0	NULL
4	NULL
1,25	NULL
(	NULL
0H1,04	NULL
_	NULL
-	NULL
+	NULL
+	NULL
+	NULL
+	NULL
+	NULL
+	NULL
+	NULL
Pre	NULL
Post	NULL
Pre	NULL
Post	NULL
Pre	NULL
Post	NULL
_	NULL
-asp	NULL
?	NULL

_	NULL
Colchicine	NULL
--	NULL
-	NULL
Fic	NULL
.	NULL

3	NULL
.	NULL

Effect	NULL
of	NULL
colchicine	NULL
on	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
,	NULL
-mediated	NULL
induction	NULL
of	NULL
24-hydroxylase	NULL
mRNA	NULL
.	NULL

Pre	NULL
,	NULL
monocytes	NULL
were	NULL
incubated	NULL
in	NULL
serum-free	NULL
media	NULL
with	NULL
0	NULL
,	NULL
10	NULL
,	NULL
25	NULL
,	NULL
or	NULL
750	NULL
uM	NULL
colchicine	NULL
for	NULL
30	NULL
min	NULL
.	NULL

Media	NULL
were	NULL
removed	NULL
,	NULL
and	NULL
cells	NULL
were	NULL
washed	NULL
and	NULL
incubated	NULL
with	NULL
0	NULL
(	NULL
-	NULL
)	NULL
or	NULL
0.24	NULL
nM	NULL
1,25	NULL
(	NULL
O0H	NULL
)	NULL
;	NULL
D	NULL
;	NULL
,	NULL
(	NULL
+	NULL
)	NULL
for	NULL
4	NULL
h.	NULL
Total	NULL
RNA	NULL
from	NULL
monocytes	NULL
was	NULL
assayed	NULL
for	NULL
mRNA	NULL
levels	NULL
of	NULL
24-hydroxylase	NULL
and	NULL
glyceraldehyde-3-phosphate	NULL
dehydrogenase	NULL
(	NULL
GAPDH	NULL
)	NULL
using	NULL
ribonuclease	NULL
protection	NULL
assay	NULL
.	NULL

A	NULL
shows	NULL
two	NULL
representative	NULL
gels	NULL
,	NULL
in	NULL
monocytes	NULL
from	NULL
the	NULL
same	NULL
individual	NULL
.	NULL

B	NULL
depicts	NULL
the	NULL
densitometric	NULL
analysis	NULL
of	NULL
the	NULL
24-hydroxylase	NULL
:	NULL
glyceraldehyde-3-phosphate	NULL
dehydrogenase	NULL
mRNA	NULL
ratios	NULL
.	NULL

Values	NULL
represent	NULL
mean	NULL
+	NULL
S.E	NULL
.	NULL

from	NULL
4	NULL
independent	NULL
experiments	NULL
performed	NULL
in	NULL
duplicate	NULL
.	NULL

that	NULL
the	NULL
inability	NULL
of	NULL
1,25	NULL
(	NULL
0H	NULL
)	NULL
,	NULL
D	NULL
;	NULL
,	NULL
to	NULL
induce	NULL
24-hydroxylase	NULL
mRNA	NULL
levels	NULL
when	NULL
microtubules	NULL
are	NULL
disrupted	NULL
with	NULL
10	NULL
uM	NULL
nocodazole	NULL
(	NULL
74	NULL
%	NULL
of	NULL
nocodazole-treated	NULL
monocytes	NULL
stained	NULL
negatively	NULL
for	NULL
polymerized	NULL
tubulin	NULL
)	NULL
can	NULL
be	NULL
totally	NULL
reversed	NULL
if	NULL
monocytes	NULL
are	NULL
allowed	NULL
to	NULL
recover	NULL
microtubular	NULL
integrity	NULL
after	NULL
removal	NULL
of	NULL
nocodazole	NULL
from	NULL
the	NULL
incubation	NULL
media	NULL
.	NULL

Effect	NULL
of	NULL
Colchicine	NULL
on	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
,	NULL
Uptake	NULL
and	NULL
Formation	NULL
of	NULL
the	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
-	NULL
VDR	NULL
Complex-To	NULL
characterize	NULL
potential	NULL
mechanisms	NULL
involved	NULL
in	NULL
the	NULL
lack	NULL
of	NULL
response	NULL
to	NULL
1,25	NULL
(	NULL
O0H	NULL
)	NULL
;	NULL
,	NULL
D	NULL
;	NULL
with	NULL
microtubule	NULL
disruption	NULL
,	NULL
we	NULL
measured	NULL
the	NULL
effect	NULL
of	NULL
the	NULL
highest	NULL
dose	NULL
of	NULL
colchicine	NULL
(	NULL
750	NULL
um	NULL
)	NULL
on	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
uptake	NULL
by	NULL
monocytes	NULL
.	NULL

Colchicine	NULL
did	NULL
not	NULL
affect	NULL
total	NULL
cellular	NULL
uptake	NULL
of	NULL
1,25	NULL
(	NULL
0H	NULL
)	NULL
,	NULL
D	NULL
;	NULL
after	NULL
a	NULL
1-h	NULL
incubation	NULL
either	NULL
at	NULL
4	NULL
°C	NULL
(	NULL
C	NULL
:	NULL
1.5	NULL
+	NULL
0.2	NULL
;	NULL
T	NULL
:	NULL
1.6	NULL
+	NULL
0.2	NULL
fmol/ug	NULL
of	NULL
DNW/h	NULL
;	NULL
n	NULL
=	NULL
3	NULL
)	NULL
or	NULL
at	NULL
37°C	NULL
(	NULL
3.0	NULL
+	NULL
0.3	NULL
versus	NULL
3.5	NULL
+	NULL
0.2	NULL
;	NULL
n	NULL
=	NULL
4	NULL
)	NULL
.	NULL

We	NULL
next	NULL
examined	NULL
whether	NULL
colchicine	NULL
affected	NULL
the	NULL
formation	NULL
of	NULL
the	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
-VDR	NULL
complex	NULL
.	NULL

In	NULL
three	NULL
independent	NULL
experiments	NULL
performed	NULL
in	NULL
triplicate	NULL
,	NULL
there	NULL
was	NULL
no	NULL
significant	NULL
difference	NULL
in	NULL
maximal	NULL
specific	NULL
binding	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
to	NULL
the	NULL
VDR	NULL
between	NULL
untreated	NULL
and	NULL
colchicine-treated	NULL
(	NULL
750	NULL
um	NULL
)	NULL
monocytes	NULL
(	NULL
C	NULL
:	NULL
0.21	NULL
+	NULL
0.02	NULL
;	NULL
T	NULL
:	NULL
0.19	NULL
+	NULL
0.01	NULL
fmol/ug	NULL
of	NULL
DNA	NULL
,	NULL
n	NULL
=	NULL
3	NULL
)	NULL
.	NULL

Effect	NULL
of	NULL
Microtubule	NULL
Disruption	NULL
on	NULL
Monocyte	NULL
1	NULL
«	NULL
-Hydroxylase	NULL
Activity-In	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
we	NULL
showed	NULL
that	NULL
colchicine	NULL
alone	NULL
markedly	NULL
reduced	NULL
monocyte	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
;	NULL
,	NULL
synthesis	NULL
,	NULL
even	NULL
at	NULL
a	NULL
10	NULL
uM	NULL
concentration	NULL
,	NULL
a	NULL
dose	NULL
only	NULL
partially	NULL
effective	NULL
in	NULL
blocking	NULL
the	NULL
response	NULL
to	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
.	NULL

To	NULL
examine	NULL
whether	NULL
this	NULL
reduction	NULL
on	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
;	NULL
D	NULL
;	NULL
synthesis	NULL
by	NULL
colchicine	NULL
was	NULL
the	NULL
result	NULL
of	NULL
impaired	NULL
protein	NULL
synthesis	NULL
,	NULL
a	NULL
known	NULL
side	NULL
effect	NULL
of	NULL
colchicine	NULL
treatment	NULL
(	NULL
30	NULL
)	NULL
that	NULL
could	NULL
lead	NULL
to	NULL
a	NULL
nonspecific	NULL
reduction	NULL
in	NULL
the	NULL
amount	NULL
of	NULL
la-hydroxylase	NULL
in	NULL
monocytes	NULL
,	NULL
we	NULL
measured	NULL
the	NULL
ef	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
22164	NULL
A	NULL
24-hydroxylase-t	NULL
we	NULL
C	NULL
APD	NULL
4	NULL
.	NULL

-n	NULL
»	NULL
|	NULL
Cll	NULL
ih	NULL
amis	NULL
on	NULL
lth	NULL
it	NULL
th	NULL
-	NULL
-	NULL
4	NULL
+	NULL
+	NULL
t	NULL
+	NULL
+	NULL
L_	NULL
LJ	NULL
10uM	NULL
10	NULL
uM	NULL
Reversed	NULL
l	NULL
Nocodazole	NULL
0.14	NULL
0.121	NULL
0.10	NULL
0.08	NULL
0.06	NULL
0.04	NULL
24-hydroxylase	NULL
/	NULL
GAPDH	NULL
0.02	NULL
0.004	NULL
-	NULL
=	NULL
+	NULL
+	NULL
+	NULL
10	NULL
uM	NULL
10	NULL
pM	NULL
Heverseﬂ	NULL
ocodazole	NULL
Fic	NULL
.	NULL

4	NULL
.	NULL

Effect	NULL
of	NULL
nocodazole	NULL
on	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
-mediated	NULL
induction	NULL
of	NULL
24-hydroxylase	NULL
mRNA	NULL
.	NULL

Monocytes	NULL
were	NULL
incubated	NULL
in	NULL
serum-free	NULL
media	NULL
with	NULL
0	NULL
or	NULL
10	NULL
uM	NULL
nocodazole	NULL
for	NULL
30	NULL
min	NULL
before	NULL
a	NULL
4-h	NULL
co-incubation	NULL
with	NULL
nocodazole	NULL
and	NULL
0	NULL
(	NULL
-	NULL
)	NULL
or	NULL
0.24	NULL
nM	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
(	NULL
+	NULL
)	NULL
for	NULL
4	NULL
h.	NULL
The	NULL
reversibility	NULL
of	NULL
nocodazole	NULL
effect	NULL
(	NULL
reversed	NULL
)	NULL
was	NULL
examined	NULL
by	NULL
removing	NULL
nocodazole	NULL
from	NULL
the	NULL
media	NULL
and	NULL
allowing	NULL
monocytes	NULL
to	NULL
recover	NULL
microtubular	NULL
assembly	NULL
for	NULL
4	NULL
h	NULL
before	NULL
an	NULL
exposure	NULL
to	NULL
0.24	NULL
nM	NULL
1,25	NULL
(	NULL
0H	NULL
)	NULL
,	NULL
D	NULL
,	NULL
for	NULL
4	NULL
h	NULL
(	NULL
+	NULL
)	NULL
.	NULL

Total	NULL
RNA	NULL
from	NULL
monocytes	NULL
was	NULL
assayed	NULL
for	NULL
mRNA	NULL
levels	NULL
of	NULL
24-hydroxylase	NULL
and	NULL
glyceraldehyde-3-phosphate	NULL
dehydrogenase	NULL
(	NULL
GAPDH	NULL
)	NULL
using	NULL
a	NULL
ribonuclease	NULL
protection	NULL
assay	NULL
.	NULL

A	NULL
shows	NULL
a	NULL
representative	NULL
gel	NULL
in	NULL
monocytes	NULL
from	NULL
the	NULL
same	NULL
individual	NULL
,	NULL
and	NULL
B	NULL
depicts	NULL
the	NULL
densitometric	NULL
analysis	NULL
of	NULL
the	NULL
24-hydroxylase	NULL
:	NULL
glyceraldehyde-3-phosphate	NULL
dehydrogenase	NULL
mRNA	NULL
ratios	NULL
.	NULL

Values	NULL
represent	NULL
mean	NULL
+	NULL
S.E	NULL
.	NULL

from	NULL
4	NULL
independent	NULL
experiments	NULL
performed	NULL
in	NULL
duplicate	NULL
.	NULL

fect	NULL
of	NULL
colchicine	NULL
treatment	NULL
(	NULL
10	NULL
and	NULL
750	NULL
um	NULL
,	NULL
30	NULL
min	NULL
)	NULL
on	NULL
the	NULL
K	NULL
,	NULL
,	NULL
,	NULL
and	NULL
V..	NULL
,	NULL
,	NULL
,	NULL
of	NULL
monocyte	NULL
la-hydroxylase	NULL
.	NULL

Table	NULL
I	NULL
shows	NULL
that	NULL
exposure	NULL
to	NULL
colchicine	NULL
did	NULL
not	NULL
affect	NULL
the	NULL
V	NULL
,	NULL
,	NULL
,	NULL
,	NULL
,	NULL
of	NULL
the	NULL
enzyme	NULL
but	NULL
caused	NULL
a	NULL
2-	NULL
to	NULL
4-fold	NULL
increase	NULL
in	NULL
the	NULL
K	NULL
,	NULL
,	NULL
,	NULL
for	NULL
25	NULL
(	NULL
OH	NULL
)	NULL
D	NULL
;	NULL
.	NULL

This	NULL
indicated	NULL
no	NULL
alteration	NULL
in	NULL
the	NULL
expression	NULL
of	NULL
monocyte	NULL
la-hydroxylase	NULL
but	NULL
a	NULL
marked	NULL
reduction	NULL
in	NULL
its	NULL
apparent	NULL
affinity	NULL
for	NULL
substrate	NULL
,	NULL
suggesting	NULL
a	NULL
role	NULL
for	NULL
microtubules	NULL
in	NULL
25	NULL
(	NULL
OH	NULL
)	NULL
D	NULL
;	NULL
transport	NULL
and/or	NULL
its	NULL
delivery	NULL
to	NULL
the	NULL
enzyme	NULL
.	NULL

Fig	NULL
.	NULL

5	NULL
shows	NULL
that	NULL
10	NULL
um	NULL
nocodazole	NULL
causes	NULL
a	NULL
similar	NULL
reduction	NULL
of	NULL
monocyte	NULL
la-hydroxylase	NULL
activity	NULL
.	NULL

If	NULL
after	NULL
microtubule	NULL
disruption	NULL
,	NULL
nocodazole	NULL
was	NULL
removed	NULL
from	NULL
the	NULL
incubation	NULL
media	NULL
and	NULL
monocytes	NULL
were	NULL
allowed	NULL
to	NULL
recover	NULL
microtubular	NULL
assembly	NULL
,	NULL
la-hydroxylase	NULL
activity	NULL
returned	NULL
to	NULL
basal	NULL
values	NULL
,	NULL
which	NULL
supports	NULL
the	NULL
fact	NULL
that	NULL
microtubular	NULL
integrity	NULL
is	NULL
necessary	NULL
for	NULL
normal	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
synthesis	NULL
by	NULL
human	NULL
monocytes	NULL
.	NULL

Effect	NULL
of	NULL
Microtubule	NULL
Disruption	NULL
on	NULL
the	NULL
Uptake	NULL
and	NULL
Intracellular	NULL
Transport	NULL
of	NULL
25	NULL
(	NULL
OH	NULL
)	NULL
D	NULL
;	NULL
in	NULL
Monocytes-Colchicine	NULL
treat-ment	NULL
,	NULL
even	NULL
at	NULL
the	NULL
highest	NULL
dose	NULL
(	NULL
750	NULL
um	NULL
,	NULL
for	NULL
30	NULL
min	NULL
)	NULL
,	NULL
did	NULL
not	NULL
affect	NULL
total	NULL
cellular	NULL
uptake	NULL
of	NULL
25	NULL
(	NULL
OH	NULL
)	NULL
D	NULL
,	NULL
(	NULL
C	NULL
:	NULL
70.3	NULL
+	NULL
21.4	NULL
;	NULL
T	NULL
:	NULL
81.5	NULL
+	NULL
16.6	NULL
fmol/ug	NULL
of	NULL
DNA¥/h	NULL
;	NULL
n	NULL
=	NULL
3	NULL
)	NULL
by	NULL
monocytes	NULL
.	NULL

To	NULL
test	NULL
whether	NULL
microtubule	NULL
disruption	NULL
affected	NULL
intracellular	NULL
25	NULL
(	NULL
OH	NULL
)	NULL
D	NULL
;	NULL
transport	NULL
,	NULL
untreated	NULL
and	NULL
colchicine-treated	NULL
monocytes	NULL
were	NULL
incubated	NULL
with	NULL
[	NULL
3H	NULL
]	NULL
25	NULL
(	NULL
OH	NULL
)	NULL
D3	NULL
for	NULL
1	NULL
h	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
cytochrome	NULL
P450	NULL
inhibitor	NULL
,	NULL
ketoconazole	NULL
(	NULL
10	NULL
pM	NULL
)	NULL
,	NULL
to	NULL
block	NULL
25	NULL
(	NULL
OH	NULL
)	NULL
D	NULL
;	NULL
,	NULL
metabolism	NULL
.	NULL

Standard	NULL
subcellular	NULL
fractionation	NULL
Role	NULL
of	NULL
Microtubules	NULL
in	NULL
Vitamin	NULL
D	NULL
Transport	NULL
and	NULL
Action	NULL
TaBur	NULL
I	NULL
Kinetic	NULL
parameters	NULL
of	NULL
the	NULL
1o-hydroxylase	NULL
of	NULL
human	NULL
monocytes	NULL
Normal	NULL
human	NULL
monocytes	NULL
were	NULL
incubated	NULL
with	NULL
0	NULL
,	NULL
10	NULL
,	NULL
or	NULL
750	NULL
uM	NULL
colchicine	NULL
for	NULL
30	NULL
min	NULL
.	NULL

Cells	NULL
were	NULL
washed	NULL
and	NULL
incubated	NULL
in	NULL
fresh	NULL
incubation	NULL
media	NULL
containing	NULL
4	NULL
different	NULL
concentrations	NULL
of	NULL
[	NULL
°H	NULL
]	NULL
25	NULL
(	NULL
OH	NULL
)	NULL
D	NULL
,	NULL
(	NULL
from	NULL
5	NULL
to	NULL
300	NULL
nM	NULL
)	NULL
at	NULL
37	NULL
°C	NULL
for	NULL
1	NULL
h.	NULL
1,25	NULL
(	NULL
O0H	NULL
)	NULL
,	NULL
D	NULL
,	NULL
synthesis	NULL
was	NULL
measured	NULL
as	NULL
outlined	NULL
under	NULL
``	NULL
Experimental	NULL
Procedures	NULL
.	NULL
``	NULL

K	NULL
,	NULL
,	NULL
and	NULL
V.	NULL
,	NULL
,	NULL
,	NULL
,	NULL
were	NULL
obtained	NULL
using	NULL
the	NULL
double	NULL
reciprocal	NULL
plot	NULL
of	NULL
Lineweaver	NULL
and	NULL
Burk	NULL
with	NULL
linear	NULL
regression	NULL
analysis	NULL
of	NULL
the	NULL
data	NULL
.	NULL

Results	NULL
are	NULL
mean	NULL
+	NULL
S.E	NULL
.	NULL

of	NULL
two	NULL
to	NULL
five	NULL
independent	NULL
experiments	NULL
performed	NULL
in	NULL
triplicate	NULL
.	NULL

£	NULL
,	NULL
Vmax	NULL
nM	NULL
fmol/	NULL
ug	NULL
DNA/h	NULL
Control	NULL
(	NULL
n	NULL
=	NULL
5	NULL
)	NULL
17.8	NULL
+	NULL
2.2	NULL
82.1	NULL
+	NULL
2.4	NULL
Colchicine	NULL
,	NULL
10	NULL
uM	NULL
(	NULL
rn	NULL
=	NULL
2	NULL
)	NULL
30.2	NULL
+	NULL
3.1	NULL
``	NULL
34.5	NULL
+	NULL
3.0	NULL
Colchicine	NULL
,	NULL
750	NULL
uM	NULL
(	NULL
n	NULL
=	NULL
3	NULL
)	NULL
52.2	NULL
+	NULL
1.7°	NULL
82.1	NULL
+	NULL
2.1	NULL
*	NULL
Differ	NULL
from	NULL
control	NULL
,	NULL
p	NULL
=	NULL
0.01	NULL
.	NULL

2	NULL
—|—	NULL
n.S	NULL
.	NULL

-	NULL
'	NULL
2	NULL
*~	NULL
ii	NULL
.	NULL

v	NULL
)	NULL
£	NULL
g	NULL
&	NULL
23	NULL
>	NULL
~	NULL
a	NULL
D	NULL
&	NULL
&	NULL
1	NULL
o	NULL
z	NULL
C	NULL
o	NULL
£	NULL
w	NULL
ZL	NULL
.	NULL

0	NULL
:	NULL
e	NULL
Be	NULL
0	NULL
10	NULL
0	NULL
10	NULL
Reversed	NULL
Nocodazole	NULL
(	NULL
uM	NULL
)	NULL
Fic	NULL
.	NULL

5	NULL
.	NULL

Effect	NULL
of	NULL
nocodazole	NULL
on	NULL
monocyte	NULL
la-hydroxylase	NULL
activity	NULL
.	NULL

Monocytes	NULL
were	NULL
incubated	NULL
with	NULL
0	NULL
or	NULL
10	NULL
uM	NULL
nocodazole	NULL
for	NULL
30	NULL
min	NULL
,	NULL
and	NULL
la-hydroxylase	NULL
activity	NULL
was	NULL
measured	NULL
as	NULL
outlined	NULL
under	NULL
``	NULL
Experimental	NULL
Procedures	NULL
.	NULL
``	NULL

To	NULL
examine	NULL
the	NULL
reversibility	NULL
of	NULL
nocodazole	NULL
effects	NULL
on	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
production	NULL
(	NULL
reversed	NULL
)	NULL
,	NULL
after	NULL
the	NULL
30-min	NULL
exposure	NULL
to	NULL
0	NULL
or	NULL
10	NULL
uM	NULL
nocodazole	NULL
,	NULL
nocodazole	NULL
was	NULL
removed	NULL
and	NULL
monocytes	NULL
were	NULL
allowed	NULL
to	NULL
recover	NULL
microtubular	NULL
assembly	NULL
for	NULL
4	NULL
h	NULL
before	NULL
assaying	NULL
1a-hydroxylase	NULL
activity	NULL
.	NULL

techniques	NULL
were	NULL
employed	NULL
,	NULL
and	NULL
the	NULL
purity	NULL
of	NULL
the	NULL
fractions	NULL
was	NULL
assessed	NULL
using	NULL
specific	NULL
markers	NULL
as	NULL
shown	NULL
in	NULL
Table	NULL
II	NULL
.	NULL

Table	NULL
III	NULL
shows	NULL
that	NULL
in	NULL
monocytes	NULL
with	NULL
intact	NULL
microtubules	NULL
,	NULL
most	NULL
of	NULL
the	NULL
25	NULL
(	NULL
OH	NULL
)	NULL
D	NULL
;	NULL
,	NULL
within	NULL
the	NULL
cell	NULL
was	NULL
associated	NULL
with	NULL
the	NULL
mitochondrial	NULL
fraction	NULL
.	NULL

Colchicine	NULL
treatment	NULL
reduced	NULL
the	NULL
uptake	NULL
of	NULL
25	NULL
(	NULL
OH	NULL
)	NULL
D	NULL
;	NULL
by	NULL
the	NULL
mitochondrial	NULL
fraction	NULL
with	NULL
a	NULL
concomitant	NULL
increase	NULL
in	NULL
the	NULL
amount	NULL
of	NULL
25	NULL
(	NULL
OH	NULL
)	NULL
D	NULL
;	NULL
in	NULL
the	NULL
cytosol	NULL
and	NULL
with	NULL
no	NULL
changes	NULL
in	NULL
the	NULL
25	NULL
(	NULL
OH	NULL
)	NULL
D	NULL
;	NULL
associated	NULL
to	NULL
microsomal	NULL
or	NULL
nuclear	NULL
fractions	NULL
.	NULL

To	NULL
test	NULL
whether	NULL
this	NULL
reduction	NULL
in	NULL
the	NULL
mitochondrial	NULL
uptake	NULL
of	NULL
25	NULL
(	NULL
OH	NULL
)	NULL
D	NULL
;	NULL
could	NULL
be	NULL
the	NULL
result	NULL
of	NULL
a	NULL
decrease	NULL
in	NULL
the	NULL
number	NULL
of	NULL
mitochondria	NULL
with	NULL
microtubule	NULL
disruption	NULL
,	NULL
we	NULL
measured	NULL
succinate	NULL
dehydrogenase	NULL
activity	NULL
in	NULL
the	NULL
mitochondrial	NULL
fraction	NULL
of	NULL
untreated	NULL
and	NULL
colchicine-treated	NULL
monocytes	NULL
.	NULL

We	NULL
found	NULL
no	NULL
changes	NULL
in	NULL
succinate	NULL
dehydrogenase	NULL
activity	NULL
(	NULL
C	NULL
:	NULL
0.022	NULL
+	NULL
0.002	NULL
;	NULL
T	NULL
:	NULL
0.020	NULL
+	NULL
0.002	NULL
umol/min/ug	NULL
of	NULL
DNA	NULL
,	NULL
n	NULL
=	NULL
2	NULL
)	NULL
with	NULL
colchicine	NULL
treatment	NULL
.	NULL

Subcellular	NULL
Localization	NULL
of	NULL
Monocyte	NULL
1	NULL
«	NULL
-Hydroxylase-The	NULL
previous	NULL
findings	NULL
also	NULL
suggested	NULL
the	NULL
mitochondrial	NULL
localization	NULL
of	NULL
monocyte	NULL
1la-hydroxylase	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
measured	NULL
1a-hy-droxylase	NULL
activity	NULL
in	NULL
mitochondrial	NULL
and	NULL
microsomal	NULL
fractions	NULL
.	NULL

In	NULL
mitochondria	NULL
,	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
production	NULL
was	NULL
0.68	NULL
+	NULL
0.07	NULL
fmol/ug	NULL
of	NULL
DNW/h	NULL
,	NULL
whereas	NULL
in	NULL
microsomes	NULL
,	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
synthesis	NULL
was	NULL
undetectable	NULL
(	NULL
0.01	NULL
+	NULL
0.01	NULL
fmol/ug	NULL
of	NULL
DNA/h	NULL
)	NULL
.	NULL

610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
Role	NULL
of	NULL
Microtubules	NULL
in	NULL
Vitamin	NULL
D	NULL
Transport	NULL
and	NULL
Action	NULL
TaBur	NULL
II	NULL
Enzymatic	NULL
characterization	NULL
of	NULL
subcellular	NULL
fractions	NULL
Succinate	NULL
dehydrogenase	NULL
and	NULL
NADPH-cytochrome	NULL
c	NULL
reductase	NULL
activities	NULL
were	NULL
measured	NULL
as	NULL
specific	NULL
mitochondrial	NULL
and	NULL
microsomal	NULL
markers	NULL
,	NULL
respectively	NULL
.	NULL

Results	NULL
are	NULL
expressed	NULL
as	NULL
percent	NULL
of	NULL
total	NULL
enzymatic	NULL
activity	NULL
.	NULL

Values	NULL
are	NULL
mean	NULL
+	NULL
S.E	NULL
.	NULL

of	NULL
three	NULL
independent	NULL
experiments	NULL
.	NULL

Succinate	NULL
NADPH-cytochrome	NULL
c	NULL
dehydrogenase	NULL
reductase	NULL
Mitochondria	NULL
70.2	NULL
+	NULL
2.5	NULL
9.3	NULL
+	NULL
1.1	NULL
Microsomes	NULL
17.5	NULL
+	NULL
1.0	NULL
74.8	NULL
+	NULL
4.8	NULL
Nuclei	NULL
+	NULL
membranes	NULL
7.8	NULL
+	NULL
1.2	NULL
12.0	NULL
+	NULL
2.1	NULL
Cytosol	NULL
5.8	NULL
+	NULL
1.0	NULL
4.9	NULL
+	NULL
1.1	NULL
TaBtE	NULL
III	NULL
Effect	NULL
of	NULL
colchicine	NULL
on	NULL
subcellular	NULL
25	NULL
(	NULL
OH	NULL
)	NULL
D	NULL
,	NULL
uptake	NULL
by	NULL
human	NULL
monocytes	NULL
Monocytes	NULL
were	NULL
exposed	NULL
to	NULL
0	NULL
,	NULL
10	NULL
,	NULL
or	NULL
750	NULL
uM	NULL
colchicine	NULL
for	NULL
30	NULL
min	NULL
,	NULL
washed	NULL
,	NULL
and	NULL
incubated	NULL
for	NULL
1	NULL
h	NULL
with	NULL
0.1	NULL
LCi	NULL
of	NULL
[	NULL
°H	NULL
]	NULL
25	NULL
(	NULL
OH	NULL
)	NULL
D	NULL
;	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
10	NULL
uM	NULL
ketoconazole	NULL
to	NULL
block	NULL
25	NULL
(	NULL
OH	NULL
)	NULL
D	NULL
,	NULL
metabolism	NULL
.	NULL

Cells	NULL
were	NULL
sonicated	NULL
for	NULL
30	NULL
s	NULL
,	NULL
and	NULL
we	NULL
measured	NULL
25	NULL
(	NULL
OH	NULL
)	NULL
D	NULL
;	NULL
associated	NULL
with	NULL
each	NULL
subcellular	NULL
fraction	NULL
obtained	NULL
by	NULL
differential	NULL
centrifugation	NULL
.	NULL

Results	NULL
were	NULL
expressed	NULL
as	NULL
percent	NULL
of	NULL
total	NULL
recovered	NULL
tritium	NULL
.	NULL

Values	NULL
are	NULL
mean	NULL
+	NULL
S.E	NULL
.	NULL

of	NULL
three	NULL
to	NULL
five	NULL
independent	NULL
experiments	NULL
performed	NULL
in	NULL
triplicate	NULL
.	NULL

Control	NULL
Colchicine	NULL
Colchicine	NULL
(	NULL
10	NULL
pm	NULL
)	NULL
(	NULL
750	NULL
pm	NULL
)	NULL
Nuclei	NULL
+	NULL
membranes	NULL
19.3	NULL
+22	NULL
20.2	NULL
+	NULL
2.8	NULL
21.0	NULL
+	NULL
1.8	NULL
Mitochondria	NULL
48.1	NULL
+	NULL
83.2	NULL
33.2	NULL
+	NULL
2.2	NULL
``	NULL
31.9	NULL
+	NULL
2.6°	NULL
Microsomes	NULL
10.1	NULL
+	NULL
0.6	NULL
9.7	NULL
+	NULL
0.8	NULL
9.2	NULL
+	NULL
0.3	NULL
Cytosol	NULL
27.3	NULL
+	NULL
2.8	NULL
364	NULL
+	NULL
1.4	NULL
``	NULL
38.2	NULL
+	NULL
2.2	NULL
``	NULL
*	NULL
p	NULL
<	NULL
0.05	NULL
from	NULL
controls	NULL
.	NULL

Clearly	NULL
,	NULL
monocyte	NULL
la-hydroxylase	NULL
,	NULL
like	NULL
the	NULL
renal	NULL
enzyme	NULL
,	NULL
is	NULL
located	NULL
exclusively	NULL
in	NULL
mitochondria	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
the	NULL
reduction	NULL
of	NULL
1,25	NULL
(	NULL
O0H	NULL
)	NULL
;	NULL
D	NULL
;	NULL
production	NULL
by	NULL
colchicine	NULL
involved	NULL
reduced	NULL
25	NULL
(	NULL
OH	NULL
)	NULL
D	NULL
;	NULL
transport	NULL
to	NULL
the	NULL
mitochondria	NULL
or	NULL
directly	NULL
impaired	NULL
mitochondrial	NULL
25	NULL
(	NULL
OH	NULL
)	NULL
D	NULL
;	NULL
up-take	NULL
,	NULL
we	NULL
measured	NULL
1	NULL
«	NULL
-hydroxylase	NULL
activity	NULL
in	NULL
(	NULL
a	NULL
)	NULL
mitochondrial	NULL
fractions	NULL
isolated	NULL
from	NULL
intact	NULL
and	NULL
colchicine-treated	NULL
monocytes	NULL
and	NULL
(	NULL
b	NULL
)	NULL
in	NULL
isolated	NULL
mitochondrial	NULL
fractions	NULL
from	NULL
intact	NULL
monocytes	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
0	NULL
or	NULL
10	NULL
um	NULL
colchicine	NULL
.	NULL

In	NULL
both	NULL
protocols	NULL
,	NULL
we	NULL
found	NULL
no	NULL
effect	NULL
of	NULL
colchicine	NULL
on	NULL
mitochondrial	NULL
1,25	NULL
(	NULL
O0H	NULL
)	NULL
;	NULL
D	NULL
;	NULL
production	NULL
(	NULL
(	NULL
a	NULL
)	NULL
control	NULL
:	NULL
0.65	NULL
+	NULL
0.12	NULL
fmol/ug	NULL
of	NULL
DNA/h	NULL
;	NULL
colchicine	NULL
:	NULL
0.63	NULL
+	NULL
0.09	NULL
,	NULL
n	NULL
=	NULL
2	NULL
;	NULL
(	NULL
b	NULL
)	NULL
control	NULL
:	NULL
0.68	NULL
+	NULL
0.07	NULL
;	NULL
colchicine	NULL
:	NULL
0.63	NULL
+	NULL
0.08	NULL
fmol	NULL
of	NULL
1,25	NULL
(	NULL
O0H	NULL
)	NULL
,	NULL
D	NULL
;	NULL
/ug	NULL
of	NULL
DNW/h	NULL
)	NULL
.	NULL

DISCUSSION	NULL
1,25	NULL
(	NULL
0H	NULL
)	NULL
;	NULL
D	NULL
;	NULL
,	NULL
the	NULL
most	NULL
active	NULL
form	NULL
of	NULL
vitamin	NULL
D	NULL
,	NULL
is	NULL
a	NULL
potent	NULL
steroid	NULL
hormone	NULL
.	NULL

Its	NULL
actions	NULL
extend	NULL
beyond	NULL
calcium	NULL
homeosta-sis	NULL
to	NULL
impact	NULL
a	NULL
variety	NULL
of	NULL
nonclassical	NULL
targets	NULL
including	NULL
the	NULL
immune	NULL
system	NULL
.	NULL

To	NULL
elicit	NULL
a	NULL
biological	NULL
response	NULL
,	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
binds	NULL
to	NULL
its	NULL
intracellular	NULL
receptor	NULL
and	NULL
translocates	NULL
to	NULL
the	NULL
nucleus	NULL
where	NULL
it	NULL
interacts	NULL
with	NULL
vitamin	NULL
D	NULL
responsive	NULL
elements	NULL
in	NULL
the	NULL
genome	NULL
(	NULL
1	NULL
,	NULL
2	NULL
)	NULL
.	NULL

A	NULL
tubulin-mediated	NULL
cytoplasm	NULL
to	NULL
nucleus	NULL
transport	NULL
system	NULL
has	NULL
been	NULL
demonstrated	NULL
using	NULL
immunocytochemistry	NULL
in	NULL
human	NULL
fibroblasts	NULL
and	NULL
osteoblast-like	NULL
cells	NULL
(	NULL
13-15	NULL
)	NULL
;	NULL
however	NULL
,	NULL
the	NULL
physiological	NULL
relevance	NULL
of	NULL
this	NULL
transport	NULL
system	NULL
in	NULL
the	NULL
response	NULL
to	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
has	NULL
not	NULL
been	NULL
examined	NULL
either	NULL
in	NULL
normal	NULL
or	NULL
pathological	NULL
states	NULL
.	NULL

In	NULL
the	NULL
present	NULL
studies	NULL
,	NULL
we	NULL
used	NULL
our	NULL
human	NULL
monocyte	NULL
model	NULL
to	NULL
define	NULL
the	NULL
physiological	NULL
role	NULL
of	NULL
microtubules	NULL
on	NULL
the	NULL
response	NULL
to	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
.	NULL

We	NULL
found	NULL
that	NULL
disruption	NULL
of	NULL
microtubule	NULL
integrity	NULL
totally	NULL
blocked	NULL
the	NULL
ability	NULL
of	NULL
exogenous	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
to	NULL
suppress	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
production	NULL
and	NULL
to	NULL
induce	NULL
24-hydroxylase	NULL
mRNA	NULL
and	NULL
activity	NULL
in	NULL
normal	NULL
human	NULL
monocytes	NULL
.	NULL

The	NULL
lack	NULL
of	NULL
response	NULL
to	NULL
exogenous	NULL
1,25	NULL
(	NULL
O0H	NULL
)	NULL
;	NULL
D	NULL
;	NULL
with	NULL
microtubular	NULL
disruption	NULL
could	NULL
not	NULL
be	NULL
attributed	NULL
to	NULL
a	NULL
reduced	NULL
uptake	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
,	NULL
by	NULL
monocytes	NULL
or	NULL
to	NULL
a	NULL
defective	NULL
formation	NULL
of	NULL
the	NULL
VDR-1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
complex	NULL
.	NULL

Clearly	NULL
,	NULL
microtubular	NULL
integrity	NULL
is	NULL
required	NULL
after	NULL
the	NULL
formation	NULL
of	NULL
the	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
,	NULL
-VDR	NULL
complex	NULL
for	NULL
monocytes	NULL
to	NULL
elicit	NULL
a	NULL
normal	NULL
22165	NULL
response	NULL
to	NULL
1,25	NULL
(	NULL
O0H	NULL
)	NULL
,	NULL
D	NULL
;	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
our	NULL
studies	NULL
could	NULL
not	NULL
demonstrate	NULL
any	NULL
direct	NULL
action	NULL
of	NULL
microtubule	NULL
disrupting	NULL
agents	NULL
on	NULL
both	NULL
genomic	NULL
effects	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
.	NULL

The	NULL
ability	NULL
of	NULL
exogenous	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
to	NULL
suppress	NULL
monocyte	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
production	NULL
and	NULL
to	NULL
induce	NULL
24-hydroxylase	NULL
mRNA	NULL
and	NULL
activity	NULL
was	NULL
not	NULL
affected	NULL
when	NULL
the	NULL
microtubule	NULL
disrupting	NULL
agent	NULL
was	NULL
added	NULL
after	NULL
exposure	NULL
to	NULL
the	NULL
sterol	NULL
for	NULL
4	NULL
h.	NULL
These	NULL
results	NULL
in	NULL
viable	NULL
human	NULL
monocytes	NULL
support	NULL
previous	NULL
reports	NULL
in	NULL
fixed	NULL
cells	NULL
(	NULL
13	NULL
,	NULL
14	NULL
)	NULL
of	NULL
cytoplasmic	NULL
VDR	NULL
localization	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
gene	NULL
activation	NULL
by	NULL
the	NULL
glucocorticoid	NULL
receptor	NULL
(	NULL
31	NULL
)	NULL
,	NULL
microtubule	NULL
integrity	NULL
is	NULL
mandatory	NULL
for	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
-VDR-mediated	NULL
modulation	NULL
of	NULL
the	NULL
transcription	NULL
of	NULL
vitamin	NULL
D	NULL
responsive	NULL
genes	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
our	NULL
findings	NULL
in	NULL
vitro	NULL
,	NULL
the	NULL
recent	NULL
clinical	NULL
demonstration	NULL
of	NULL
a	NULL
phenotype	NULL
of	NULL
vitamin	NULL
D-resistant	NULL
rickets	NULL
type	NULL
1	NULL
,	NULL
caused	NULL
by	NULL
a	NULL
defective	NULL
nuclear	NULL
translocation	NULL
of	NULL
an	NULL
otherwise	NULL
normal	NULL
VDR	NULL
(	NULL
32	NULL
)	NULL
,	NULL
emphasizes	NULL
the	NULL
critical	NULL
role	NULL
of	NULL
the	NULL
tubulin	NULL
transport	NULL
system	NULL
mediating	NULL
cytoplasmic	NULL
to	NULL
nuclear	NULL
VDR-1,25	NULL
(	NULL
O0H	NULL
)	NULL
;	NULL
D	NULL
;	NULL
translocation	NULL
in	NULL
1,25	NULL
(	NULL
0H	NULL
)	NULL
;	NULL
,	NULL
D	NULL
;	NULL
action	NULL
.	NULL

The	NULL
present	NULL
studies	NULL
also	NULL
demonstrated	NULL
that	NULL
disruption	NULL
of	NULL
microtubular	NULL
integrity	NULL
significantly	NULL
decreased	NULL
the	NULL
ability	NULL
of	NULL
human	NULL
monocytes	NULL
to	NULL
synthesize	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
.	NULL

Since	NULL
colchicine	NULL
was	NULL
reported	NULL
to	NULL
decrease	NULL
protein	NULL
synthesis	NULL
(	NULL
30	NULL
)	NULL
,	NULL
we	NULL
examined	NULL
whether	NULL
this	NULL
reduction	NULL
in	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
generation	NULL
was	NULL
mediated	NULL
by	NULL
a	NULL
decreased	NULL
expression	NULL
of	NULL
monocyte	NULL
la-hydroxylase	NULL
.	NULL

Kinetic	NULL
analysis	NULL
demonstrated	NULL
that	NULL
disruption	NULL
of	NULL
microtubular	NULL
assembly	NULL
did	NULL
not	NULL
affect	NULL
the	NULL
V	NULL
,	NULL
,	NULL
,	NULL
,	NULL
,	NULL
of	NULL
the	NULL
enzyme	NULL
but	NULL
markedly	NULL
reduced	NULL
its	NULL
apparent	NULL
affinity	NULL
for	NULL
its	NULL
substrate	NULL
,	NULL
25	NULL
(	NULL
0H	NULL
)	NULL
D	NULL
;	NULL
.	NULL

Further	NULL
characterization	NULL
of	NULL
the	NULL
mechanisms	NULL
mediating	NULL
this	NULL
increase	NULL
in	NULL
the	NULL
K	NULL
,	NULL
,	NULL
,	NULL
for	NULL
25	NULL
(	NULL
OH	NULL
)	NULL
D	NULL
;	NULL
showed	NULL
that	NULL
microtubule	NULL
disruption	NULL
did	NULL
not	NULL
affect	NULL
whole	NULL
cell	NULL
uptake	NULL
of	NULL
25	NULL
(	NULL
OH	NULL
)	NULL
D	NULL
;	NULL
,	NULL
but	NULL
markedly	NULL
decreased	NULL
its	NULL
intracellular	NULL
delivery	NULL
to	NULL
the	NULL
mitochondria	NULL
,	NULL
suggesting	NULL
a	NULL
role	NULL
for	NULL
microtubules	NULL
in	NULL
intracellular	NULL
25	NULL
(	NULL
OH	NULL
)	NULL
D	NULL
;	NULL
transport	NULL
.	NULL

We	NULL
have	NULL
also	NULL
demonstrated	NULL
that	NULL
the	NULL
reduction	NULL
in	NULL
mitochondrial	NULL
25	NULL
(	NULL
OH	NULL
)	NULL
D	NULL
;	NULL
uptake	NULL
could	NULL
not	NULL
be	NULL
attributed	NULL
to	NULL
a	NULL
reduction	NULL
in	NULL
the	NULL
number	NULL
of	NULL
mitochondria	NULL
since	NULL
succinate	NULL
dehydrogenase	NULL
activity	NULL
was	NULL
not	NULL
decreased	NULL
in	NULL
colchicine-treated	NULL
monocytes	NULL
.	NULL

The	NULL
observation	NULL
that	NULL
la-hydroxylase	NULL
activity	NULL
in	NULL
isolated	NULL
mitochondria	NULL
was	NULL
not	NULL
affected	NULL
by	NULL
a	NULL
dose	NULL
of	NULL
colchicine	NULL
that	NULL
effectively	NULL
reduced	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
production	NULL
by	NULL
intact	NULL
monocytes	NULL
indicates	NULL
no	NULL
direct	NULL
effect	NULL
of	NULL
colchicine	NULL
on	NULL
mitochondrial	NULL
25	NULL
(	NULL
OH	NULL
)	NULL
D	NULL
;	NULL
uptake	NULL
or	NULL
enzymatic	NULL
activity	NULL
.	NULL

Thus	NULL
,	NULL
contrary	NULL
to	NULL
the	NULL
well	NULL
accepted	NULL
theory	NULL
of	NULL
simple	NULL
diffusion	NULL
of	NULL
25	NULL
(	NULL
OH	NULL
)	NULL
D	NULL
;	NULL
due	NULL
to	NULL
its	NULL
lipophilic	NULL
nature	NULL
,	NULL
microtubules	NULL
participate	NULL
in	NULL
the	NULL
intracellular	NULL
transport	NULL
of	NULL
25	NULL
(	NULL
OH	NULL
)	NULL
D	NULL
;	NULL
to	NULL
the	NULL
mitochondrial	NULL
la-hydroxylase	NULL
of	NULL
human	NULL
monocytes	NULL
.	NULL

Similarly	NULL
,	NULL
cytoskeletal	NULL
components	NULL
were	NULL
shown	NULL
to	NULL
mediate	NULL
the	NULL
transport	NULL
of	NULL
adrenal	NULL
steroid	NULL
precursors	NULL
to	NULL
the	NULL
mitochondria	NULL
,	NULL
thus	NULL
limiting	NULL
the	NULL
rate	NULL
of	NULL
synthesis	NULL
of	NULL
adrenal	NULL
steroids	NULL
(	NULL
33	NULL
)	NULL
.	NULL

A	NULL
mitochondrial	NULL
localization	NULL
of	NULL
monocyte	NULL
1	NULL
«	NULL
-hydroxylase	NULL
was	NULL
also	NULL
demonstrated	NULL
in	NULL
the	NULL
chick	NULL
myelomonocytic	NULL
cell	NULL
line	NULL
HD11	NULL
(	NULL
27	NULL
)	NULL
,	NULL
and	NULL
the	NULL
kinetics	NULL
of	NULL
the	NULL
avian	NULL
enzyme	NULL
has	NULL
marked	NULL
similarities	NULL
with	NULL
the	NULL
la-hydroxylase	NULL
expressed	NULL
in	NULL
human	NULL
pulmonary	NULL
alveolar	NULL
macrophages	NULL
in	NULL
sar-coidosis	NULL
(	NULL
34	NULL
,	NULL
35	NULL
)	NULL
.	NULL

Similar	NULL
to	NULL
our	NULL
finding	NULL
of	NULL
impaired	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
synthesis	NULL
by	NULL
monocytes	NULL
with	NULL
microtubular	NULL
disruption	NULL
,	NULL
reduction	NULL
in	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
production	NULL
by	NULL
vinblastine	NULL
was	NULL
demonstrated	NULL
in	NULL
renal	NULL
tubules	NULL
from	NULL
vitamin	NULL
D-deficient	NULL
chicks	NULL
(	NULL
36	NULL
)	NULL
.	NULL

However	NULL
,	NULL
for	NULL
the	NULL
avian	NULL
renal	NULL
enzyme	NULL
,	NULL
there	NULL
was	NULL
no	NULL
actual	NULL
reduction	NULL
in	NULL
total	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
synthesized	NULL
but	NULL
an	NULL
impaired	NULL
exit	NULL
of	NULL
the	NULL
sterol	NULL
from	NULL
the	NULL
mitochondria	NULL
and	NULL
out	NULL
of	NULL
the	NULL
renal	NULL
epithelial	NULL
cells	NULL
.	NULL

On	NULL
the	NULL
contrary	NULL
,	NULL
in	NULL
our	NULL
human	NULL
monocyte	NULL
model	NULL
,	NULL
we	NULL
measured	NULL
the	NULL
total	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
,	NULL
generated	NULL
regardless	NULL
of	NULL
its	NULL
subcellular	NULL
or	NULL
extracellular	NULL
location	NULL
,	NULL
and	NULL
we	NULL
found	NULL
a	NULL
marked	NULL
decrease	NULL
in	NULL
1,25	NULL
(	NULL
O0H	NULL
)	NULL
;	NULL
,	NULL
D	NULL
;	NULL
levels	NULL
with	NULL
microtubule	NULL
disruption	NULL
with	NULL
no	NULL
alteration	NULL
in	NULL
the	NULL
V.	NULL
,	NULL
,	NULL
,	NULL
,	NULL
of	NULL
the	NULL
enzyme	NULL
.	NULL

Therefore	NULL
,	NULL
despite	NULL
the	NULL
similarities	NULL
in	NULL
subcellular	NULL
localization	NULL
and	NULL
regulation	NULL
of	NULL
the	NULL
la	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
22166	NULL
hydroxylase	NULL
of	NULL
human	NULL
monocytes	NULL
,	NULL
it	NULL
is	NULL
clear	NULL
that	NULL
the	NULL
effects	NULL
of	NULL
microtubular	NULL
disruption	NULL
on	NULL
the	NULL
intracellular	NULL
transport	NULL
of	NULL
vitamin	NULL
D	NULL
metabolites	NULL
vary	NULL
with	NULL
cell	NULL
type	NULL
,	NULL
species	NULL
,	NULL
and	NULL
vitamin	NULL
D	NULL
status	NULL
.	NULL

If	NULL
the	NULL
cytoskeletal	NULL
abnormalities	NULL
reported	NULL
for	NULL
platelets	NULL
in	NULL
chronic	NULL
uremia	NULL
(	NULL
37	NULL
)	NULL
are	NULL
present	NULL
in	NULL
other	NULL
cell	NULL
types	NULL
such	NULL
as	NULL
renal	NULL
epithelia	NULL
or	NULL
peripheral	NULL
monocytes	NULL
,	NULL
it	NULL
is	NULL
likely	NULL
that	NULL
a	NULL
defective	NULL
intracellular	NULL
25	NULL
(	NULL
OH	NULL
)	NULL
D	NULL
;	NULL
transport	NULL
may	NULL
partially	NULL
explain	NULL
the	NULL
need	NULL
for	NULL
supraphysiological	NULL
concentrations	NULL
of	NULL
25	NULL
(	NULL
OH	NULL
)	NULL
D	NULL
;	NULL
to	NULL
correct	NULL
renal	NULL
(	NULL
38	NULL
,	NULL
39	NULL
)	NULL
and	NULL
extrarenal	NULL
(	NULL
40	NULL
,	NULL
41	NULL
)	NULL
1,25	NULL
(	NULL
O0H	NULL
)	NULL
;	NULL
D	NULL
;	NULL
production	NULL
in	NULL
chronic	NULL
renal	NULL
failure	NULL
.	NULL

Our	NULL
finding	NULL
of	NULL
a	NULL
higher	NULL
K	NULL
,	NULL
,	NULL
,	NULL
for	NULL
25	NULL
(	NULL
OH	NULL
)	NULL
D	NULL
;	NULL
in	NULL
the	NULL
1	NULL
«	NULL
-hydroxylase	NULL
of	NULL
monocytes	NULL
from	NULL
hemodial-ysis	NULL
patients	NULL
(	NULL
42	NULL
)	NULL
seems	NULL
to	NULL
support	NULL
this	NULL
hypothesis	NULL
.	NULL

These	NULL
cytoskeletal	NULL
abnormalities	NULL
may	NULL
also	NULL
affect	NULL
the	NULL
translocation	NULL
of	NULL
the	NULL
1,25	NULL
(	NULL
O0H	NULL
)	NULL
,	NULL
D	NULL
;	NULL
-VDR	NULL
complex	NULL
causing	NULL
the	NULL
abnormal	NULL
response	NULL
to	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
of	NULL
chronic	NULL
renal	NULL
failure	NULL
.	NULL

In	NULL
summary	NULL
,	NULL
in	NULL
normal	NULL
monocytes	NULL
,	NULL
microtubules	NULL
mediate	NULL
intracellular	NULL
transport	NULL
of	NULL
25	NULL
(	NULL
OH	NULL
)	NULL
D	NULL
;	NULL
to	NULL
the	NULL
mitochondria	NULL
and	NULL
the	NULL
translocation	NULL
of	NULL
the	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
-receptor	NULL
complex	NULL
to	NULL
the	NULL
nucleus	NULL
.	NULL

Disruption	NULL
of	NULL
microtubular	NULL
integrity	NULL
markedly	NULL
impaired	NULL
1,25	NULL
(	NULL
O0H	NULL
)	NULL
,	NULL
D	NULL
;	NULL
synthesis	NULL
by	NULL
the	NULL
mitochondrial	NULL
1	NULL
«	NULL
-hydroxylase	NULL
and	NULL
totally	NULL
blocked	NULL
the	NULL
ability	NULL
of	NULL
monocytes	NULL
to	NULL
respond	NULL
to	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
which	NULL
clearly	NULL
indicate	NULL
the	NULL
physiological	NULL
and/or	NULL
pathophysiological	NULL
relevance	NULL
of	NULL
the	NULL
tubulin-transport	NULL
system	NULL
in	NULL
humans	NULL
.	NULL

Acknowledgments-We	NULL
thank	NULL
Dr.	NULL
Alex	NULL
J	NULL
.	NULL

Brown	NULL
and	NULL
Dr.	NULL
Stephen	NULL
Gluck	NULL
for	NULL
suggestions	NULL
and	NULL
helpful	NULL
discussions	NULL
.	NULL

We	NULL
also	NULL
thank	NULL
Jane	NULL
L.	NULL
Finch	NULL
and	NULL
Rhonda	NULL
Coursey-Pratt	NULL
for	NULL
their	NULL
assistance	NULL
in	NULL
the	NULL
preparation	NULL
of	NULL
the	NULL
manuscript	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Pike	NULL
,	NULL
J.	NULL
W.	NULL
(	NULL
1982	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

257	NULL
,	NULL
6766-6775	NULL
2	NULL
.	NULL

Pike	NULL
,	NULL
J.	NULL
W.	NULL
,	NULL
and	NULL
Haussler	NULL
,	NULL
M.	NULL
R.	NULL
(	NULL
1983	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

79	NULL
,	NULL
7719-7723	NULL
3	NULL
.	NULL

Papamichail	NULL
,	NULL
M.	NULL
,	NULL
Tsokos	NULL
,	NULL
G.	NULL
,	NULL
Tsawdaroglou	NULL
,	NULL
N.	NULL
,	NULL
and	NULL
Sekeris	NULL
,	NULL
C.	NULL
E.	NULL
(	NULL
1980	NULL
)	NULL
Exp	NULL
.	NULL

Cell	NULL
.	NULL

Res	NULL
.	NULL

125	NULL
,	NULL
490-493	NULL
.	NULL

Akner	NULL
,	NULL
G.	NULL
,	NULL
Sundquist	NULL
,	NULL
K.	NULL
G.	NULL
,	NULL
Denis	NULL
,	NULL
M.	NULL
,	NULL
Wikstom	NULL
,	NULL
A.	NULL
C.	NULL
,	NULL
and	NULL
Gustatssin	NULL
,	NULL
J	NULL
.	NULL

A	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Eur	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

53	NULL
,	NULL
390-401	NULL
.	NULL

Antakly	NULL
,	NULL
T.	NULL
(	NULL
1984	NULL
)	NULL
Endocrinology	NULL
115	NULL
,	NULL
1984-1989	NULL
.	NULL

Walters	NULL
,	NULL
M.	NULL
R.	NULL
(	NULL
1985	NULL
)	NULL
Endocrine	NULL
Rev	NULL
.	NULL

6	NULL
,	NULL
512-543	NULL
.	NULL

Pratt	NULL
,	NULL
W.	NULL
B	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268	NULL
,	NULL
21455-21458	NULL
.	NULL

Gibbons	NULL
,	NULL
I.	NULL
R.	NULL
(	NULL
1988	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268	NULL
,	NULL
15837-15840	NULL
.	NULL

Spindler	NULL
,	NULL
B.	NULL
J.	NULL
,	NULL
MacLeod	NULL
,	NULL
K.	NULL
M.	NULL
,	NULL
Ring	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Baxter	NULL
,	NULL
J.	NULL
D.	NULL
(	NULL
1975	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

250	NULL
,	NULL
4113-4119	NULL
10	NULL
.	NULL

Walters	NULL
,	NULL
S.	NULL
N.	NULL
,	NULL
Reinhardt	NULL
,	NULL
T.	NULL
A.	NULL
,	NULL
Bominick	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
Horst	NULL
,	NULL
R.	NULL
L.	NULL
,	NULL
and	NULL
Littledike	NULL
E.	NULL
T.	NULL
(	NULL
1986	NULL
)	NULL
Arch	NULL
.	NULL

Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

246	NULL
,	NULL
366-373	NULL
11	NULL
.	NULL

Haussler	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
Mangelsdorf	NULL
,	NULL
D.	NULL
J.	NULL
,	NULL
Komm	NULL
,	NULL
K.	NULL
S.	NULL
,	NULL
Terpening	NULL
,	NULL
C.	NULL
M.	NULL
,	NULL
Yamaoka	NULL
,	NULL
>	NULL
to	NULL
to	NULL
1	NULL
O	NULL
of	NULL
12	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

28.	NULL
.	NULL

Reinhardt	NULL
,	NULL
T.	NULL
A.	NULL
,	NULL
Horst	NULL
,	NULL
R.	NULL
L.	NULL
,	NULL
Orf	NULL
,	NULL
W.	NULL
,	NULL
and	NULL
Hollis	NULL
,	NULL
B.	NULL
W.	NULL
(	NULL
1984	NULL
)	NULL
J.	NULL
Clin	NULL
.	NULL

25.	NULL
.	NULL

Keenan	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
and	NULL
Holmes	NULL
,	NULL
R.	NULL
P.	NULL
(	NULL
1991	NULL
)	NULL
Int	NULL
.	NULL

J.	NULL
Biochem	NULL
.	NULL

28	NULL
,	NULL
1225-1230	NULL
27	NULL
.	NULL

28.	NULL
.	NULL

Schachter	NULL
,	NULL
H.	NULL
,	NULL
Jabbal	NULL
,	NULL
I.	NULL
,	NULL
Hudgin	NULL
,	NULL
R.	NULL
L.	NULL
,	NULL
Pinteric	NULL
,	NULL
L.	NULL
,	NULL
Mc	NULL
Guire	NULL
,	NULL
E.	NULL
J.	NULL
,	NULL
and	NULL
30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

Role	NULL
of	NULL
Microtubules	NULL
in	NULL
Vitamin	NULL
D	NULL
Transport	NULL
and	NULL
Action	NULL
K.	NULL
,	NULL
Allerretto	NULL
,	NULL
E.	NULL
A.	NULL
,	NULL
Baker	NULL
,	NULL
A.	NULL
R.	NULL
,	NULL
Shine	NULL
,	NULL
J.	NULL
,	NULL
McDonnell	NULL
,	NULL
D.	NULL
P.	NULL
,	NULL
and	NULL
Hughes	NULL
,	NULL
M.	NULL
(	NULL
1988	NULL
)	NULL
Recent	NULL
Prog	NULL
.	NULL

Horm	NULL
.	NULL

Res	NULL
.	NULL

44	NULL
,	NULL
263-305	NULL
Barsony	NULL
,	NULL
J.	NULL
,	NULL
McCoy	NULL
,	NULL
D.	NULL
W.	NULL
,	NULL
Lieberman	NULL
,	NULL
M.	NULL
E.	NULL
,	NULL
and	NULL
Renyi	NULL
,	NULL
I.	NULL
in	NULL
Vitamin	NULL
D	NULL
,	NULL
a	NULL
Therapeutic	NULL
Steroid	NULL
Hormone	NULL
:	NULL
Structural	NULL
Studies	NULL
,	NULL
Molecular	NULL
Endocrinol-ogy	NULL
,	NULL
and	NULL
Clinical	NULL
Applications	NULL
(	NULL
Norman	NULL
,	NULL
A.	NULL
W.	NULL
,	NULL
Bouillon	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Thomas-set	NULL
,	NULL
M.	NULL
,	NULL
eds	NULL
)	NULL
pp	NULL
.	NULL

345-346	NULL
,	NULL
Walter	NULL
de	NULL
Gruyter	NULL
,	NULL
Berlin	NULL
.	NULL

Barsony	NULL
,	NULL
J.	NULL
,	NULL
Pike	NULL
,	NULL
J.	NULL
W.	NULL
,	NULL
Deluca	NULL
,	NULL
H.	NULL
F.	NULL
,	NULL
and	NULL
Marx	NULL
,	NULL
S.	NULL
J	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
J	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

111	NULL
,	NULL
2385-2395	NULL
.	NULL

Amizuka	NULL
,	NULL
N.	NULL
,	NULL
and	NULL
Ozawa	NULL
,	NULL
H.	NULL
(	NULL
1992	NULL
)	NULL
Arch	NULL
.	NULL

Histol	NULL
.	NULL

Cytol	NULL
.	NULL

55	NULL
,	NULL
77-88	NULL
.	NULL

Barsony	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
McKoy	NULL
,	NULL
W.	NULL
(	NULL
1992	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

267	NULL
,	NULL
24457-24465	NULL
.	NULL

Bhalla	NULL
,	NULL
A.	NULL
K.	NULL
,	NULL
Amento	NULL
,	NULL
E.	NULL
P.	NULL
,	NULL
Clemens	NULL
,	NULL
T.	NULL
L.	NULL
,	NULL
Hollick	NULL
,	NULL
M.	NULL
F.	NULL
,	NULL
and	NULL
Krane	NULL
,	NULL
S.	NULL
M.	NULL
(	NULL
1983	NULL
)	NULL
Cell	NULL
Immunol	NULL
.	NULL

98	NULL
,	NULL
311-322	NULL
Bar-Shavit	NULL
,	NULL
Z.	NULL
,	NULL
Noff	NULL
,	NULL
D.	NULL
,	NULL
Eldestein	NULL
,	NULL
S.	NULL
,	NULL
Meyer	NULL
,	NULL
M.	NULL
,	NULL
Shibolet	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Goldman	NULL
,	NULL
R.	NULL
(	NULL
1981	NULL
)	NULL
Calcif	NULL
.	NULL

Tissue	NULL
.	NULL

Int	NULL
.	NULL

88	NULL
,	NULL
673-676	NULL
Bhalla	NULL
,	NULL
A.	NULL
K.	NULL
,	NULL
Amento	NULL
,	NULL
E.	NULL
P.	NULL
,	NULL
and	NULL
Krane	NULL
,	NULL
S.	NULL
M.	NULL
(	NULL
1986	NULL
)	NULL
Cell	NULL
Immunol	NULL
.	NULL

98	NULL
,	NULL
311-322	NULL
Cohen	NULL
,	NULL
M.	NULL
S.	NULL
,	NULL
Mesler	NULL
,	NULL
D.	NULL
E.	NULL
,	NULL
Snipes	NULL
,	NULL
R.	NULL
G.	NULL
,	NULL
and	NULL
Gray	NULL
,	NULL
T.	NULL
K.	NULL
(	NULL
1986	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

136	NULL
,	NULL
1049-1053	NULL
Koren	NULL
,	NULL
R.	NULL
,	NULL
Ravid	NULL
,	NULL
A.	NULL
,	NULL
Rottem	NULL
,	NULL
C.	NULL
,	NULL
Shohami	NULL
,	NULL
E.	NULL
,	NULL
Liberman	NULL
,	NULL
E.	NULL
A.	NULL
,	NULL
and	NULL
Novogrod-sky	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1986	NULL
)	NULL
FEBS	NULL
Lett	NULL
.	NULL

205	NULL
,	NULL
113-116	NULL
Dusso	NULL
,	NULL
A.	NULL
S.	NULL
,	NULL
Finch	NULL
,	NULL
J.	NULL
,	NULL
Brown	NULL
,	NULL
A.	NULL
,	NULL
Ritter	NULL
,	NULL
C.	NULL
,	NULL
Delmez	NULL
,	NULL
J.	NULL
,	NULL
Schreiner	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
Slatopolsky	NULL
,	NULL
E.	NULL
(	NULL
1991	NULL
)	NULL
J.	NULL
Clin	NULL
.	NULL

Endocrinol	NULL
.	NULL

Metab	NULL
.	NULL

72	NULL
,	NULL
157-164	NULL
Dusso	NULL
,	NULL
A.	NULL
,	NULL
Kamimura	NULL
,	NULL
S.	NULL
,	NULL
Gallieni	NULL
,	NULL
M.	NULL
,	NULL
Mori	NULL
,	NULL
T.	NULL
,	NULL
Nishii	NULL
,	NULL
Y.	NULL
,	NULL
and	NULL
Slatopolsky	NULL
,	NULL
E.	NULL
(	NULL
1992	NULL
)	NULL
J	NULL
.	NULL

Bone	NULL
Miner	NULL
.	NULL

Res	NULL
.	NULL

4	NULL
,	NULL
S151	NULL
Yam	NULL
,	NULL
L.	NULL
T.	NULL
,	NULL
Li	NULL
,	NULL
C.	NULL
T	NULL
,	NULL
and	NULL
Crosby	NULL
,	NULL
W.	NULL
H.	NULL
(	NULL
1971	NULL
)	NULL
Am	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Pathol	NULL
.	NULL

55	NULL
,	NULL
283-290	NULL
Endocrinol	NULL
.	NULL

Metab	NULL
.	NULL

58	NULL
,	NULL
91-98	NULL
LePacq	NULL
,	NULL
J	NULL
.	NULL

B.	NULL
,	NULL
and	NULL
Paoletti	NULL
,	NULL
C.	NULL
(	NULL
1966	NULL
)	NULL
Anal	NULL
.	NULL

Biochem	NULL
.	NULL

17	NULL
,	NULL
100-107	NULL
Shany	NULL
,	NULL
S.	NULL
,	NULL
Ren	NULL
,	NULL
S.	NULL
Y.	NULL
,	NULL
Arbelle	NULL
,	NULL
J.	NULL
,	NULL
Clemens	NULL
,	NULL
T.	NULL
L.	NULL
,	NULL
and	NULL
Adams	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
J	NULL
.	NULL

Bone	NULL
Miner	NULL
.	NULL

Res	NULL
.	NULL

8	NULL
,	NULL
269-276	NULL
Green	NULL
,	NULL
D.	NULL
E.	NULL
,	NULL
Mii	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Kohout	NULL
,	NULL
P.	NULL
M.	NULL
(	NULL
1955	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

260	NULL
,	NULL
551-567	NULL
Roseman	NULL
,	NULL
S.	NULL
(	NULL
1970	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

245	NULL
,	NULL
1090-1100	NULL
Stetson	NULL
,	NULL
D.	NULL
L.	NULL
,	NULL
and	NULL
Steinmetz	NULL
,	NULL
P.	NULL
R.	NULL
(	NULL
1983	NULL
)	NULL
Am	NULL
.	NULL

J.	NULL
Physiol	NULL
.	NULL

245	NULL
,	NULL
C113-C120	NULL
Spazary	NULL
,	NULL
D.	NULL
,	NULL
Barber	NULL
,	NULL
T.	NULL
,	NULL
Dwyer	NULL
,	NULL
N.	NULL
K.	NULL
,	NULL
Blanchette-Mackie	NULL
,	NULL
E.	NULL
J.	NULL
,	NULL
and	NULL
Stoney	NULL
Simon	NULL
,	NULL
S.	NULL
(	NULL
1994	NULL
)	NULL
J.	NULL
Steroid	NULL
Biochem	NULL
.	NULL

Mol	NULL
.	NULL

Biol	NULL
.	NULL

51	NULL
,	NULL
143-148	NULL
Hewison	NULL
,	NULL
M.	NULL
,	NULL
Rut	NULL
,	NULL
A.	NULL
R.	NULL
,	NULL
Kristjansson	NULL
,	NULL
K.	NULL
,	NULL
Walker	NULL
,	NULL
R.	NULL
E.	NULL
,	NULL
Dillon	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
Hughes	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
and	NULL
O'Riordan	NULL
,	NULL
J.	NULL
L.	NULL
H.	NULL
(	NULL
1993	NULL
)	NULL
Clin	NULL
.	NULL

Endocrinol	NULL
.	NULL

89	NULL
,	NULL
663-670	NULL
DiBartolomeis	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
and	NULL
Jefcoate	NULL
,	NULL
C.	NULL
R.	NULL
(	NULL
1984	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

259	NULL
,	NULL
10159-10167	NULL
Adams	NULL
,	NULL
J.	NULL
S.	NULL
,	NULL
and	NULL
Gacad	NULL
,	NULL
M.	NULL
A	NULL
.	NULL

(	NULL
1985	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

161	NULL
,	NULL
755-765	NULL
Adams	NULL
,	NULL
J.	NULL
S.	NULL
,	NULL
Ren	NULL
,	NULL
S.	NULL
Y.	NULL
,	NULL
Arbelle	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
Horiuchi	NULL
,	NULL
N.	NULL
,	NULL
Gray	NULL
,	NULL
R.	NULL
W.	NULL
,	NULL
Clements	NULL
,	NULL
T.	NULL
L.	NULL
,	NULL
and	NULL
Shany	NULL
,	NULL
S.	NULL
(	NULL
1994	NULL
)	NULL
Endocrinology	NULL
184	NULL
,	NULL
2567-2573	NULL
Taft	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
and	NULL
Larkins	NULL
,	NULL
R.	NULL
G.	NULL
(	NULL
1986	NULL
)	NULL
Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

Res	NULL
.	NULL

Commun	NULL
.	NULL

1984	NULL
,	NULL
218-226	NULL
Escolar	NULL
,	NULL
G.	NULL
,	NULL
Diaz-Ricart	NULL
,	NULL
M.	NULL
,	NULL
Cases	NULL
,	NULL
A.	NULL
,	NULL
Castillo	NULL
,	NULL
R.	NULL
,	NULL
Ordinas	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
White	NULL
,	NULL
J.	NULL
G.	NULL
(	NULL
1993	NULL
)	NULL
Am	NULL
.	NULL

J.	NULL
Pathol	NULL
.	NULL

148	NULL
,	NULL
828-831	NULL
Halloran	NULL
,	NULL
B.	NULL
P.	NULL
,	NULL
Schaeffer	NULL
,	NULL
P.	NULL
,	NULL
Lifschitz	NULL
,	NULL
M.	NULL
,	NULL
Levens	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Goldsmith	NULL
,	NULL
R.	NULL
S.	NULL
(	NULL
1984	NULL
)	NULL
J.	NULL
Clin	NULL
.	NULL

Endocrinol	NULL
.	NULL

Metab	NULL
.	NULL

59	NULL
,	NULL
1063-1069	NULL
Dusso	NULL
,	NULL
A.	NULL
,	NULL
Lopez-Hilker	NULL
,	NULL
S.	NULL
,	NULL
Finch	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
Grooms	NULL
,	NULL
P.	NULL
,	NULL
Brown	NULL
,	NULL
A.	NULL
,	NULL
Martin	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Slatopolsky	NULL
,	NULL
E.	NULL
(	NULL
1989	NULL
)	NULL
Kidney	NULL
Int	NULL
.	NULL

85	NULL
,	NULL
860-864	NULL
Lambert	NULL
,	NULL
P.	NULL
W.	NULL
,	NULL
Stern	NULL
,	NULL
P.	NULL
H.	NULL
,	NULL
Avioli	NULL
,	NULL
R.	NULL
C.	NULL
,	NULL
Brackett	NULL
,	NULL
N.	NULL
C.	NULL
,	NULL
Turner	NULL
,	NULL
R.	NULL
T.	NULL
,	NULL
Greene	NULL
,	NULL
A.	NULL
,	NULL
Fu	NULL
,	NULL
I.	NULL
Y.	NULL
,	NULL
and	NULL
Bell	NULL
,	NULL
N.	NULL
H.	NULL
(	NULL
1982	NULL
)	NULL
J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

69	NULL
,	NULL
722-725	NULL
Dusso	NULL
,	NULL
A.	NULL
,	NULL
Lopez-Hilker	NULL
,	NULL
S.	NULL
,	NULL
Rapp	NULL
,	NULL
N.	NULL
,	NULL
and	NULL
Slatopolsky	NULL
,	NULL
E.	NULL
(	NULL
1988	NULL
)	NULL
Kidney	NULL
Int	NULL
.	NULL

34	NULL
,	NULL
368-375	NULL
Gallieni	NULL
,	NULL
M.	NULL
,	NULL
Kamimura	NULL
,	NULL
S.	NULL
,	NULL
Ahmed	NULL
,	NULL
A.	NULL
,	NULL
Bravo	NULL
,	NULL
E.	NULL
,	NULL
Delmez	NULL
,	NULL
J.	NULL
,	NULL
Slatopolsky	NULL
,	NULL
E.	NULL
,	NULL
and	NULL
Dusso	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Am	NULL
.	NULL

J.	NULL
Physiol	NULL
.	NULL

87	NULL
,	NULL
F7AG-F753	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
Microtubules	NULL
Mediate	NULL
Cellular	NULL
25-Hydroxyvitamin	NULL
D3	NULL
Trafficking	NULL
and	NULL
the	NULL
Genomic	NULL
Response	NULL
to	NULL
1,25-Dihydroxyvitamin	NULL
D	NULL
3	NULL
in	NULL
Normal	NULL
Human	NULL
Monocytes	NULL
Shigehito	NULL
Kamimura	NULL
,	NULL
Maurizio	NULL
Gallieni	NULL
,	NULL
Min	NULL
Zhong	NULL
,	NULL
Walter	NULL
Beron	NULL
,	NULL
Eduardo	NULL
Slatopolsky	NULL
and	NULL
Adriana	NULL
Dusso	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

1995	NULL
,	NULL
270:22160-22166.	NULL
doi	NULL
:	NULL
10.1074/jb0.270.38.22160	NULL
Access	NULL
the	NULL
most	NULL
updated	NULL
version	NULL
of	NULL
this	NULL
article	NULL
at	NULL
http	NULL
:	NULL
/www.jbe.org/content/270/38/22160	NULL
Alerts	NULL
:	NULL
«	NULL
When	NULL
this	NULL
article	NULL
is	NULL
cited	NULL
«	NULL
When	NULL
a	NULL
correction	NULL
for	NULL
this	NULL
article	NULL
is	NULL
posted	NULL
Click	NULL
here	NULL
to	NULL
choose	NULL
from	NULL
all	NULL
of	NULL
JBC	NULL
's	NULL
e-mail	NULL
alerts	NULL
This	NULL
article	NULL
cites	NULL
41	NULL
references	NULL
,	NULL
10	NULL
of	NULL
which	NULL
can	NULL
be	NULL
accessed	NULL
free	NULL
at	NULL
http	NULL
:	NULL
//www	NULL
.	NULL

full.html	NULL
#	NULL
ref-list-1	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
4q	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL

